
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 10.1021/acsomega.9b02853ArticleNickel-Catalyzed Amidoalkylation Reaction of γ-Hydroxy
Lactams: An Access to 3-Substituted Isoindolinones† Zhang Shuo ‡Shi Xinhua ‡Li Jichao ‡Hou Zitong ‡Song Zihe ‡Su Xiaofeng ‡Peng Dan *‡Wang Feng ‡Yu Yitao ‡Zhao Guilong *§‡ Shandong
Provincial Key Laboratory for Special Silicone-Containing Materials,
Advanced Materials Institute, Qilu University
of Technology (Shandong Academy of Sciences), Jinan 250014, P. R. China§ Department
of Drug Discovery, Guangzhou Lixin Pharmaceuticals,
Inc., Guangzhou 510535, P. R. China* E-mail: lonarpeng@aliyun.com (D.P.).* E-mail: zhao_guilong@126.com (G.Z.).05 11 2019 19 11 2019 4 21 19420 19436 03 09 2019 23 10 2019 Copyright © 2019 American Chemical Society2019American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

An efficient Ni(ClO4)2·6H2O-promoted amidoalkylation
reaction for the synthesis of 3-substituted
isoindolinones involving various γ-hydroxy lactams and nucleophiles
has been successfully developed. The transformation proceeds with
both carbon (ketones and arenes) and heteroatom (alcohols, thiols,
and amines) nucleophiles and in both intermolecular and intramolecular
manners. The prominent features of the present strategy are wide substrate
scope, excellent group tolerability, and moderate to good yields (up
to 96% yield). The present strategy is also characterized by remarkable
superiority over the current synthetic methods. Furthermore, the reaction
could be scaled up to the multigram scale.

document-id-old-9ao9b02853document-id-new-14ao9b02853ccc-price
==== Body
Introduction
It is well known that
isoindolinones are important structural motifs
in natural products and pharmaceuticals. Among isoindolinones, the
3-substituted isoindolinone moiety is frequently found in a few alkaloids.1 For example, nuevamine 1 is the first known isoindoloisoquinoline
alkaloid and lennoxamine 2 is an isoindolobenzazepine alkaloid; both
of them are isolated from Berberis darwinii.2 Pestalachloride A 3 is an antifungal
alkaloid, which is isolated from Pestalotiopsis adust.3 Pagoclone 4 and pazinaclone 5 are anticonvulsant
and anxiolytic drugs,4 PD-172938 6 shows
affinity toward dopamine D4 receptors,5 and compound 7 is a non-nucleoside HIV-1 reverse transcriptase inhibitor
(Figure 1).6 Apart from these drug candidates, the 3-substituted
isoindolinones show many other biological activities, including antipsychotic,7 antihypertensive,8 antiulcer,9 and anxiolytic10 properties.

Figure 1 Examples of naturally occurring and biologically
active C(3)-substituted
isoindolinones.

The development of a bond-forming
reaction between electrophiles
and nucleophiles needs a suitable catalyst system; various Lewis acids
were successfully used for the activation of both electrophiles and
nucleophiles.11 On the other hand, acyliminium
ions represent important electron-deficient carbocation intermediates
in organic synthesis because they provide various biologically important
natural and unnatural products via C–C and C-heteroatom bond-forming
methodologies using an inter- or intramolecular path.12,13 The removal of a good leaving group at the α-position of amides
or lactams generates usually N-acyliminium ions,
which act as more electron-deficient carbocations toward nucleophiles.
In this regard, chiral thiourea derivatives,14,15 superacidic reagents,16 and Lewis17 and Brønsted acidic18 systems are used for the generation of N-acyliminium ions and subsequent amidoalkylation reactions (Scheme 1). In addition, utilization
of transition metals, such as AuI/AgI,19 Sn(NTf)4,20 and PdII–AgI,21 for nucleophilic addition of γ-hydroxy lactams, CuII-catalyzed reaction for the addition of N-acyliminium
ions and diaryl malonote,22 and Pd for
an asymmetric reaction between malonates and dihydroisoquinolines23 is noteworthy. Herein, we report an efficient
NiII-promoted amidoalkylation reaction for the synthesis
of 3-substituted isoindolinones involving various γ-hydroxy
lactams and a variety of C/N/O/S nucleophiles in both intermolecular
and intramolecular amidoalkylation manners.

Scheme 1 Catalytic α-Amidoalkylation
Reaction
Results and Discussion
Initially, for the template study of the amidoalkylation reaction
of 1a and 2a to 3a, a broad
set of reaction parameters were examined including the solvent, temperature,
and different Lewis acid catalysts. Ni(ClO4)2·6H2O was found to be superior, as only 10 mol %
of the catalyst was required to perform the amidoalkylation reaction
at 100 °C and a quantitative yield of the product 3a was obtained in 3 h (Table 1, entry 1). Ni(ClO4)2·6H2O remained catalytically active for a wide range of temperatures
(80–120 °C) and for polar solvents like 1,2-dichloroethane
(DCE), tetrahydrofuran (THF), and acetonitrile (entries 1–5).
However, in toluene, the reaction did not proceed at all even after
12 h (entry 6). Anhydrous SnCl2 or SnCl4 was
also effective for the amidoalkylation reaction (entries 7 and 8).
Moreover, Lewis acidic Sc(OTf)3, Y(OTf)3, Yb(OTf),
La(OTf)3, In(OTf)3, and Cu(OTf)2 were
also found to be less efficient to catalyze the amidoalkylation compared
to Ni(ClO4)2·6H2O (entries 9–14).
From the above screening, the supremacy of Ni(ClO4)2·6H2O over conventional Lewis acids including
several widely used metal triflates to carry out the amidoalkylation
reaction was established.

Table 1 Screening and Optimization
of Reaction
Conditionsa
entry	catalyst	solvent	temp (°C)	t (h)	yield%b	
1	Ni(CI04)2·6H2O	DCE	100	3	92	
2	Ni(CI04)2·6H2O	DCE	80	3	83	
3	Ni(CI04)2·6H2O	DCE	120	3	92	
4	Ni(CI04)2·6H2O	THF	100	5	67	
5	Ni(CI04)2·6H2O	CH3CN	100	5	82	
6	Ni(CI04)2·6H2O	toluene	100	12	0	
7	SnCI2	DCE	100	12	0	
8	SnCI4	DCE	100	12	0	
9	Sc(OTf)3	DCE	100	12	75	
10	Y(OTf)3	DCE	100	12	32	
11	Yb(OTf)3	DCE	100	12	45	
12	La(OTf)3	DCE	100	12	23	
13	ln(OTf)3	DCE	100	12	18	
14	Cu(OTf)2	DCE	100	12	23	
a Reaction conditions: 1a (0.2 mmol), 2a (0.24 mmol), the catalyst (0.02 mmol)
in the solvent (2 mL), a sealed tube.

b Isolated yield.

After having the optimized conditions in hand, we next investigated
the scope and limitation of the method. First, a variety of ketone
derivatives (1a–o) were exposed to
standard reaction conditions, and the results are summarized in Table 2. A variety of electronically
rich, neutral and poor ketones were well tolerated under the standard
conditions and afforded the corresponding substituted isoindolinones
(3a–k) in good to excellent yields
(85–96%). Various functional groups of ketones such as fluoro,
chloro, bromo, nitro, cyano, alkyl, methoxy, and acetoxy, were well
tolerated and produced the corresponding substituted isoindolinones
(3a–k). Under standard reaction conditions,
moderate to good yields (82–87%) were achieved for the reaction
between 1-(4-nitrophenyl)ethan-1-one and various γ-hydroxy lactam
derivatives [3-hydroxy-2-isopropylisoindolin-1-one, 3-hydroxy-2-phenylisoindolin-1-one,
3-hydroxy-2-(p-tolyl)isoindolin-1-one, 2-(4-fluorobenzyl)-3-hydroxyisoindolin-1-one,
2-(4-chlorobenzyl)-3-hydroxyisoindolin-1-one, 3-hydroxy-2-(4-methylbenzyl)isoindolin-1-one,
and 2-(4-chlorophenethyl)-3-hydroxyisoindolin-1-one]. On the other
hand, a relatively lower yield (82%) of the product was achieved in
the case of 2-(4-fluorobenzyl)-3-hydroxyisoindolin-1-one, which suggests
that both the generation and stability of the N-acyliminium
ion are important for the reaction.

Table 2 Substrate Scope of
the Intermolecular
Amidoalkylation Reaction via Ketone Nucleophiles Catalyzed by Ni(ClO4)2·6H2Oa
a Reaction conditions: 1 (0.2 mmol), 2 (0.24 mmol), Ni(ClO4)2·6H2O (10 mol %), DCE (2 mL), 100 °C,
a sealed tube, 3 h, isolated yield.

Then, we investigated the scope of the amidoalkylation
reaction
with respect to arenes. Thus, 2-benzyl-3-hydroxyisoindolin-1-one was
reacted with various arene derivatives (1,3,5-trimethoxybenzene, mesitylene,
and 2-methylthiophene) under the standard conditions, and the results
are presented in Table 3. As shown in Table 3, it is evident that arene derivatives were well tolerated to optimized
conditions and afforded 3-substituted isoindolinones (5a–c) in good yields (90–92%).

Table 3 Substrate Scope of the Intermolecular
Amidoalkylation Reaction via Arene Nucleophiles Catalyzed by Ni(ClO4)2·6H2Oa
a Reaction conditions: 1 (0.2 mmol), 4 (0.24 mmol), Ni(ClO4)2·6H2O (10 mol %), DCE (2 mL), 100 °C,
a sealed tube, 3 h, isolated yield.

The success of the above intermolecular amidoalkylation
reaction
encouraged us to investigate intramolecular cyclizations of the N-acyliminium ions for the synthesis of [2,3]-fused isoindolinone
derivatives. Under standard reaction conditions, moderate to good
yields (82–91%) were achieved for the reaction with a variety
of γ-hydroxy-N-phenylethyl-lactams (Table 4). On the other hand,
electron-poor arenes such as 3-hydroxy-2-(4-(trifluoromethyl)phenethyl)isoindolin-1-one
remained unreactive toward the cyclization reaction.

Table 4 Substrate Scope of the Intramolecular
Amidoalkylation Reaction Catalyzed by Ni(ClO4)2·6H2Oa
a Reaction conditions: 1 (0.2 mmol), 4 (0.24 mmol), Ni(ClO4)2·6H2O (10 mol %), DCE (2 mL), 100 °C,
a sealed tube, 3 h, isolated yield.

Encouraged by the transformation proceeding with different
carbon
(ketones and arenes) nucleophiles in the intermolecular and intramolecular
amidoalkylation discussed above, we tried to broaden the scope with
different types of oxygen (alcohols), sulfur (thiols), and nitrogen
(amines) nucleophiles. First, the reaction with different oxygen nucleophiles
was tested, and the results are summarized in Table 5. Thus, a variety of primary and secondary
alcohols were well tolerated under the standard conditions and afforded
the corresponding 3-O-substituted isoindolinones (8a–l) with moderate to excellent yields (85–92%). Under
standard reaction conditions, moderate to good yields (85–93%)
were achieved for the reaction between ethanol and various γ-hydroxy
lactam derivatives [2-(4-fluorobenzyl)-3-hydroxyisoindolin-1-one,
3-hydroxy-2-(4-methylbenzyl)isoindolin-1-one, 3-hydroxy-2-(p-tolyl)isoindolin-1-one, 3-hydroxy-2-phenylisoindolin-1-one,
2-(4-chlorophenethyl)-3-hydroxyisoindolin-1-one, and 2-(4-chlorophenyl)-3-hydroxyisoindolin-1-one].

Table 5 Substrate Scope of the Intermolecular
Amidoalkylation Reaction via Alcohol Nucleophiles Catalyzed by Ni(ClO4)2·6H2Oa
a Reaction conditions: 1 (0.2 mmol), 4 (0.24 mmol), Ni(ClO4)2·6H2O (10 mol %), DCE (2 mL), 100 °C,
a sealed tube, 3 h, isolated yield.

Similarly, sulfur nucleophiles like ethanethiol, propane-1-thiol,
butane-1-thiol, pentane-1-thiol, heptane-1-thiol, propane-2-thiol,
cyclopentanethiol, and 2-methylpropane-1-thiol were also found to
provide 3-S-substituted isoindolinone products (10a–h) in good yields (85–92%). Additionally, in the α-amidoalkylation
reaction of heteroatom nucleophiles, sulfur nucleophiles like phenylmethanethiol, p-tolylmethanethiol, (4-chlorophenyl)methanethiol, (4-(tert-butyl)phenyl)methanethiol, and ethyl 2-mercaptoacetate
were also tested and the results were delightful, we could obtain
the corresponding 3-S-substituted isoindolinones in good yield (85−94%).
To further augment the reactivity, we conducted the reaction between
propane-1-thiol and various γ-hydroxy lactam derivatives [4-((1-hydroxy-3-oxoisoindolin-2-yl)methyl)benzonitrile,
3-hydroxy-2-phenylisoindolin-1-one, 3-hydroxy-2-(p-tolyl)isoindolin-1-one, 2-(4-chlorophenethyl)-3-hydroxyisoindolin-1-one,
3-hydroxy-2-phenethylisoindolin-1-one, 3-hydroxy-2-(4-methylphenethyl)isoindolin-1-one,
and 3-hydroxy-2-(4-methoxybenzyl)isoindolin-1-one].

Also, nitrogen
nucleophiles like thiomorpholine, morpholine, phenylmethanamine,
(4-fluorophenyl)methanamine, (4-chlorophenyl)methanamine, (4-bromophenyl)methanamine,
(2-chlorophenyl)methanamine, o-tolylmethanamine,
and furan-2-ylmethanamine were found to provide corresponding 3-N-substituted
isoindolinone products (12a–i) in
good yields (81–95%). Additionally, in the α-amidoalkylation
reaction of heteroatom nucleophiles, we conducted the reaction between
thiomorpholine and various γ-hydroxy lactam derivatives [3-hydroxy-2-phenylisoindolin-1-one,
3-hydroxy-2-(p-tolyl)isoindolin-1-one, 3-hydroxy-2-isopropylisoindolin-1-one,
3-hydroxy-2-phenethylisoindolin-1-one, 3-hydroxy-2-(4-methoxyphenethyl)isoindolin-1-one,
2-(4-chlorophenethyl)-3-hydroxyisoindolin-1-one, 3-hydroxy-2-(4-methylphenethyl)isoindolin-1-one,
3-hydroxy-2-(4-methylbenzyl)isoindolin-1-one, and 2-(4-fluorobenzyl)-3-hydroxyisoindolin-1-one]
and obtained good yields (85–92%) (Table 6 and 7).

Table 6 Substrate
Scope of the Intermolecular
Amidoalkylation Reaction via Thiol Nucleophiles Catalyzed by Ni(ClO4)2·6H2Oa
a Reaction conditions: 1 (0.2 mmol), 4 (0.24 mmol), Ni(ClO4)2·6H2O (10 mol %), DCE (2 mL), 100 °C,
a sealed tube, 3 h, isolated yield.

Table 7 Substrate Scope of the Intermolecular
Amidoalkylation Reaction via Amine Nucleophiles Catalyzed by Ni(ClO4)2·6H2Oa
a Reaction conditions: 1 (0.2 mmol), 4 (0.24 mmol), Ni(ClO4)2·6H2O (10 mol %), DCE (2 mL), 100 °C,
a sealed tube, 3 h, isolated yield.

To demonstrate the scalability of this process, gram-scale
reactions
were performed (Scheme 2). 1-(4-Nitrophenyl)ethan-1-one, ethanol, propane-1-thiol, and thiomorpholine
were well tolerated under the standard conditions and afforded the
corresponding 3-substituted isoindolinones with good yields (85–96%).

Scheme 2 Gram-Scale Synthesis of 3-Substituted Isoindolinones
Based on these results and reported literature,24 a possible reaction mechanism is proposed in Scheme 3. We propose that
Ni(ClO4)2·6H2O acts as a Lewis
acid to
activate and facilitate the departure of a 3-hydroxyl group to form
the acyliminium ions. The nucleophilic attack of different carbon
(ketones and arenes) and heteroatom (alcohols, thiols, and amines)
nucleophiles on the N-acyliminium ion forms a C–C
bond or a C–X (O, S, and N) bond, followed by the deprotonation
of the intermediate, affording the desired 3-substituted isoindolinones.

Scheme 3 Possible Reaction Pathways
Conclusions
In summary, we have developed an efficient and practical method
for the synthesis of 3-substituted isoindolinones involving various
γ-hydroxy lactams and nucleophiles through the amidoalkylation
reaction promoted by Ni(ClO4)2·6H2O. The transformation proceeds with C/O/S/N nucleophiles in the intermolecular
and intramolecular manners. Furthermore, the method offers several
advantages such as a wide variety of substrates, excellent group tolerability,
easy handling, and good yields (up to 96% yield). Moreover, the 3-substituted
isoindolinones products could be prepared on a gram scale.

Experimental
Section
General Details
Unless otherwise noted, all of the
reagents were obtained commercially and used without further purification
and reactions were monitored by thin-layer chromatography (TLC) using
an ethyl acetate/petroleum ether (60–90 °C boiling mixture)
mixture as the eluent. Column chromatography was performed on silica
gel (200–300 mesh) using different percentages of ethyl acetate
in petroleum ether. 1H NMR (400 MHz) and 13C
NMR (100 MHz) spectra were recorded in CDCl3 on a Bruker
400 MHz spectrometer with tetramethylsilane (TMS) as an internal standard.
High-resolution mass spectra (HRMS) were recorded on the Q-TOF6510
instruments.

Synthesis of Isoindoline-1,3-dione Derivatives
In a
100 mL round-bottom flask, phthalic anhydride (7.4 g, 50 mmol) and
the corresponding amine (50 mmol) were added to 50 mL of acetic acid,
and the mixture was refluxed at 120 °C for 10 h. After completion
of the reaction, water (100 mL) was added to the reaction mixture
and the solution was extracted with CH2Cl2 (50
mL × 3). The combined organic layer was dried with anhydrous
Na2SO4 and evaporated under reduced pressure.
The residue was purified through column chromatography to afford the
product isoindoline-1,3-dione derivatives.

Synthesis of γ-Hydroxy
Lactam Derivatives
A 25
mL round-bottom flask was charged with isoindoline-1,3-dione derivatives
(2 mmol), methanol (10 mL), and a stirring bar. The flask was cooled
to 0 °C. Then, sodium borohydride (370 mg, 10 mmol) was added
portionwise over 5 min. The reaction mixture was stirred for 3 h.
The conversion was measured by TLC (ethyl acetate/petroleum ether).
If all of the starting material was not consumed after 3 h, 5 additional
equivalents of sodium borohydride were added every 30 min until full
conversion was realized. Upon complete conversion of the isoindoline-1,3-dione
derivatives, the methanol was removed under vacuum and the reaction
mixture was poured into a saturated aqueous solution of sodium hydrogen
carbonate (20 mL) and then extracted with ethyl acetate (10 mL ×
3). The combined organic extracts were dried over anhydrous sodium
sulfate and evaporated to leave the hydroxy lactams, which were then
purified by column on silica gel using a mixture of ethyl acetate/petroleum
ether as the eluent to furnish the γ-hydroxy lactam derivatives.

General Procedure for the Nickel-Catalyzed Amidoalkylation Reaction
of γ-Hydroxy Lactams
A 35 mL sealed tube was charged
with γ-hydroxy lactams (0.2 mmol), different nucleophiles (0.24
mol), and Ni(ClO4)2·6H2O (0.02
mol), and then 1,2-dichloroethane (DCE, 2 mL) was added. The resulting reaction mixture was kept at 100 °C for 8 h while
it was periodically checked by TLC for completion of the reaction.
The reaction mixture was cooled to room temperature and then extracted
with dichloromethane (DCM, 2 × 10 mL). The organic layer was
washed successively with water (2 × 10 mL) and brine (1 ×
10 mL), followed by the removal of DCM under reduced pressure. The
crude product was subjected to column chromatography (silica gel,
gradient elution with different percentages of EtOAc in petroleum
ether) to yield 3-substituted isoindolinones.

2-Benzyl-3-(2-oxo-2-phenylethyl)isoindolin-1-one
(3a)13a
White solid
(62.7 mg, 92%),
mp = 97–98 °C. 1H NMR (400 MHz, CDCl3) δ 7.95–7.85 (m, 1H), 7.79 (d, J =
7.3 Hz, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.51–7.44
(m, 2H), 7.40 (dd, J = 14.5, 6.8 Hz, 3H), 7.20 (ddt, J = 13.9, 9.6, 6.9 Hz, 5H), 5.31–5.18 (m, 1H), 5.06
(d, J = 15.4 Hz, 1H), 4.53 (d, J = 15.4 Hz, 1H), 3.49 (dd, J = 17.6, 5.3 Hz, 1H),
3.14 (dd, J = 17.6, 7.2 Hz, 1H). 13C NMR
(100 MHz, CDCl3) δ 197.09, 168.55, 145.90, 137.16,
136.30, 133.67, 131.84, 131.78, 128.71, 128.46, 128.05, 128.03, 128.00,
127.97, 127.52, 123.89, 122.88, 55.92, 44.66, 42.10. HRMS [electrospray
ionization (ESI)] calcd for C23H20NO2 [M + H]+ 342.1489, found 342.1490.

2-Benzyl-3-(2-(4-nitrophenyl)-2-oxoethyl)isoindolin-1-one
(3b)25
White solid
(73.3
mg, 95%), mp = 158–160 °C. 1H NMR (400 MHz,
CDCl3) δ 8.22 (d, J = 8.8 Hz, 2H),
7.93 (dd, J = 5.7, 2.5 Hz, 1H), 7.86 (d, J = 8.8 Hz, 2H), 7.60–7.45 (m, 2H), 7.44–7.35
(m, 1H), 7.16 (ddd, J = 24.9, 14.2, 7.1 Hz, 5H),
5.28 (t, J = 6.0 Hz, 1H), 4.88 (d, J = 15.5 Hz, 1H), 4.74 (d, J = 15.5 Hz, 1H), 3.47
(dd, J = 17.9, 5.9 Hz, 1H), 3.19 (dd, J = 17.9, 6.2 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 195.57, 168.54, 150.51, 145.32, 140.43, 137.11, 131.99,
131.78, 129.01, 128.77, 128.72, 127.90, 127.54, 124.11, 123.80, 122.51,
55.88, 45.00, 42.90. HRMS (ESI) calcd for C23H19N2O4 [M + H]+ 387.1339, found 387.1340.

4-(2-(2-Benzyl-3-oxoisoindolin-1-yl)acetyl)benzonitrile (3c)
White solid (70.3 mg, 96%), mp = 180–182
°C. 1H NMR (400 MHz, CDCl3) δ 7.92
(dd, J = 5.5, 2.8 Hz, 1H), 7.80 (d, J = 8.4 Hz, 2H), 7.69 (d, J = 8.3 Hz, 2H), 7.57–7.45
(m, 2H), 7.41–7.31 (m, 1H), 7.24–7.02 (m, 5H), 5.26
(t, J = 6.0 Hz, 1H), 4.89 (d, J =
15.5 Hz, 1H), 4.70 (d, J = 15.5 Hz, 1H), 3.45 (dd, J = 17.9, 5.8 Hz, 1H), 3.15 (dd, J = 17.9,
6.4 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ
195.77, 168.53, 145.37, 138.98, 137.09, 132.46, 131.97, 131.76, 128.71,
128.37, 127.89, 127.53, 124.06, 122.55, 117.70, 116.80, 55.85, 44.94,
42.61. HRMS (ESI) calcd for C24H19N2O2 [M + H]+ 367.1441, found 367.1440.

2-Benzyl-3-(2-oxo-2-(4-(trifluoromethyl)phenyl)ethyl)isoindolin-1-one
(3d)
White solid (77.7 mg, 95%), mp = 162–163
°C. 1H NMR (400 MHz, CDCl3) δ 7.91
(dd, J = 5.6, 2.6 Hz, 1H), 7.84 (d, J = 8.1 Hz, 2H), 7.66 (d, J = 8.2 Hz, 2H), 7.54–7.44
(m, 2H), 7.41–7.35 (m, 1H), 7.25–7.15 (m, 4H), 7.12
(t, J = 7.0 Hz, 1H), 5.26 (t, J =
6.1 Hz, 1H), 4.94 (d, J = 15.5 Hz, 1H), 4.66 (d, J = 15.5 Hz, 1H), 3.48 (dd, J = 17.8, 5.6
Hz, 1H), 3.17 (dd, J = 17.8, 6.6 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 196.15, 168.54, 145.55,
138.78, 137.10, 134.81 (q, J = 32.5 Hz), 131.93,
131.78, 128.61, 128.12 (q, J = 370 Hz), 125.70 (q, J = 3.5 Hz), 124.00, 122.65, 122.09, 55.89, 44.86, 42.53.
HRMS (ESI) calcd for C24H19F3NO2 [M + H]+ 410.1362, found 410.1363.

2-Benzyl-3-(2-(2-nitrophenyl)-2-oxoethyl)isoindolin-1-one
(3e)
White solid (71.8 mg, 93%), mp = 145–147
°C. 1H NMR (400 MHz, CDCl3) δ 8.18–7.97
(m, 1H), 7.95–7.79 (m, 1H), 7.66–7.41 (m, 5H), 7.37–7.20
(m, 5H), 6.83 (dd, J = 7.1, 1.7 Hz, 1H), 5.11 (dd, J = 16.1, 10.6 Hz, 2H), 4.55 (d, J = 15.4
Hz, 1H), 3.28 (ddd, J = 24.7, 18.3, 5.5 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 199.01, 168.56,
145.53, 145.11, 137.33, 136.78, 134.32, 132.01, 131.77, 130.92, 128.86,
128.60, 128.12, 127.64, 127.27, 124.45, 123.88, 122.85, 55.37, 45.55,
44.69. HRMS (ESI) calcd for C23H19N2O4 [M + H]+ 387.1339, found 387.1336.

2-Benzyl-3-(2-(4-fluorophenyl)-2-oxoethyl)isoindolin-1-one
(3f)
White solid (67.0 mg, 93%), mp = 152–154
°C. 1H NMR (400 MHz, CDCl3) δ 7.90
(dd, J = 5.3, 3.0 Hz, 1H), 7.79 (dd, J = 8.7, 5.4 Hz, 2H), 7.47 (dd, J = 9.0, 5.5 Hz,
2H), 7.43–7.34 (m, 1H), 7.28–7.11 (m, 5H), 7.07 (t, J = 8.6 Hz, 2H), 5.24 (t, J = 6.2 Hz, 1H),
4.99 (d, J = 15.4 Hz, 1H), 4.59 (d, J = 15.4 Hz, 1H), 3.43 (dd, J = 17.6, 5.5 Hz, 1H),
3.11 (dd, J = 17.6, 6.9 Hz, 1H). 13C NMR
(100 MHz, CDCl3) δ 195.43, 168.54, 166.00 (d, J = 255 Hz), 167.27, 164.72, 145.77, 137.16, 132.74 (d, J = 3.0 Hz), 131.86, 131.77, 130.78, 130.68, 128.59 (d, J = 17.1 Hz), 127.94, 127.50, 123.92, 122.77, 115.93, 115.71,
55.96, 44.75, 42.09. HRMS (ESI) calcd for C23H19FNO2 [M + H]+ 360.1394, found 360.1395.

2-Benzyl-3-(2-(2-chlorophenyl)-2-oxoethyl)isoindolin-1-one
(3g)
White solid (69.8 mg, 93%), mp = 132–134
°C. 1H NMR (400 MHz, CDCl3) δ 7.88
(d, J = 6.7 Hz, 1H), 7.55–7.39 (m, 3H), 7.34
(t, J = 6.7 Hz, 2H), 7.32–7.18 (m, 7H), 5.26–4.99
(m, 2H), 4.50 (d, J = 15.4 Hz, 1H), 3.57 (dd, J = 17.7, 4.9 Hz, 1H), 3.22 (dd, J = 17.7,
7.1 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ
199.64, 168.49, 145.36, 138.14, 137.16, 132.40, 131.84, 131.80, 131.12,
130.73, 129.23, 128.81, 128.53, 127.95, 127.61, 127.05, 123.90, 122.78,
55.82, 45.95, 44.60. HRMS (ESI) calcd for C23H19ClNO2 [M + H]+ 376.1099, found 376.1097.

2-Benzyl-3-(2-(4-bromophenyl)-2-oxoethyl)isoindolin-1-one (3h)26
White solid (75.2
mg, 90%), mp = 137–138 °C. 1H NMR (400 MHz,
CDCl3) δ 7.97–7.81 (m, 1H), 7.61 (d, J = 8.5 Hz, 2H), 7.57–7.50 (m, 2H), 7.47 (dd, J = 8.9, 5.3 Hz, 2H), 7.40–7.32 (m, 1H), 7.25–7.04
(m, 5H), 5.23 (t, J = 6.1 Hz, 1H), 4.98 (d, J = 15.4 Hz, 1H), 4.59 (d, J = 15.4 Hz,
1H), 3.42 (dd, J = 17.6, 5.5 Hz, 1H), 3.10 (dd, J = 17.6, 6.9 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 196.06, 168.52, 145.69, 137.14, 134.97, 131.99,
131.88, 131.77, 129.51, 128.91, 128.71, 128.54, 127.93, 127.52, 123.94,
122.74, 55.91, 44.77, 42.13. HRMS (ESI) calcd for C23H19BrNO2 [M + H]+ 420.0594, found 420.0595.

2-Benzyl-3-(2-(4-methoxyphenyl)-2-oxoethyl)isoindolin-1-one
(3i)26
Yellow oil
(63.1 mg, 85%). 1H NMR (400 MHz, CDCl3) δ
7.96–7.84 (m, 1H), 7.78 (d, J = 8.9 Hz, 2H),
7.45 (dd, J = 8.8, 5.1 Hz, 2H), 7.42–7.34
(m, 1H), 7.28–7.08 (m, 5H), 6.88 (d, J = 8.9
Hz, 2H), 5.23 (dd, J = 6.8, 5.7 Hz, 1H), 5.07 (d, J = 15.4 Hz, 1H), 4.50 (d, J = 15.4 Hz,
1H), 3.85 (s, 3H), 3.43 (dd, J = 17.3, 5.3 Hz, 1H),
3.09 (dd, J = 17.3, 7.4 Hz, 1H). 13C NMR
(100 MHz, CDCl3) δ 195.48, 168.55, 163.94, 146.03,
137.21, 131.79, 131.77, 130.41, 129.47, 128.67, 128.38, 127.99, 127.49,
123.82, 122.95, 113.87, 56.07, 55.55, 44.60, 41.67. HRMS (ESI) calcd
for C24H22NO3 [M + H]+ 372.1594, found 372.1594.

2-Benzyl-3-(2-(naphthalen-2-yl)-2-oxoethyl)isoindolin-1-one
(3j)
White solid (68.0 mg, 87%), mp = 172–174
°C. 1H NMR (400 MHz, CDCl3) δ 8.67
(d, J = 8.6 Hz, 1H), 7.94 (d, J =
8.2 Hz, 1H), 7.92–7.87 (m, 1H), 7.85 (d, J = 8.0 Hz, 1H), 7.61 (dd, J = 11.2, 4.1 Hz, 1H),
7.52 (dd, J = 18.0, 7.6 Hz, 2H), 7.46–7.38
(m, 3H), 7.34 (t, J = 7.7 Hz, 1H), 7.28 (d, J = 6.5 Hz, 2H), 7.21 (q, J = 7.3 Hz, 3H),
5.34–5.22 (m, 1H), 5.12 (d, J = 15.4 Hz, 1H),
4.55 (d, J = 15.4 Hz, 1H), 3.59 (dd, J = 17.3, 5.3 Hz, 1H), 3.24 (dd, J = 17.3, 7.1 Hz,
1H). 13C NMR (100 MHz, CDCl3) δ 200.56,
168.58, 145.75, 137.26, 134.52, 133.97, 133.60, 131.85, 130.07, 128.80,
128.62, 128.49, 128.47, 128.41, 128.00, 127.58, 126.69, 125.60, 124.26,
123.94, 122.80, 56.28, 45.05, 44.70. HRMS (ESI) calcd for C27H22NO2 [M + H]+ 392.1645, found
392.1645.

2-Benzyl-3-(2-(3,4-dimethylphenyl)-2-oxoethyl)isoindolin-1-one
(3k)
White solid (63.5 mg, 86%), mp = 135–137
°C. 1H NMR (400 MHz, CDCl3) δ 7.97–7.73
(m, 1H), 7.59 (s, 1H), 7.53 (d, J = 7.9 Hz, 1H),
7.45 (dd, J = 8.7, 5.1 Hz, 2H), 7.41–7.36
(m, 1H), 7.24 (q, J = 7.3 Hz, 4H), 7.17 (dd, J = 10.4, 7.4 Hz, 2H), 5.22 (dd, J = 7.1,
5.5 Hz, 1H), 5.10 (d, J = 15.3 Hz, 1H), 4.48 (d, J = 15.3 Hz, 1H), 3.48 (dd, J = 17.4, 5.2
Hz, 1H), 3.11 (dd, J = 17.4, 7.4 Hz, 1H), 2.30 (s,
3H), 2.27 (s, 3H). 13C NMR (100 MHz, CDCl3)
δ 196.97, 168.54, 146.04, 143.37, 137.23, 137.12, 134.34, 131.78,
129.94, 129.20, 128.69, 128.38, 128.06, 128.01, 127.96, 127.50, 125.82,
123.83, 122.97, 55.99, 44.57, 41.95, 20.07, 19.75. HRMS (ESI) calcd
for C25H24NO2 [M + H]+ 370.1802, found 370.1803.

2-Isopropyl-3-(2-(4-nitrophenyl)-2-oxoethyl)isoindolin-1-one
(3l)
White solid (55.4 mg, 82%), mp = 142–144
°C. 1H NMR (400 MHz, CDCl3) δ 8.32
(d, J = 8.8 Hz, 2H), 8.13 (d, J =
8.8 Hz, 2H), 7.87–7.70 (m, 1H), 7.48–7.38 (m, 2H), 7.38–7.30
(m, 1H), 5.36 (dd, J = 8.6, 3.5 Hz, 1H), 4.24 (dt, J = 13.8, 6.9 Hz, 1H), 3.72 (dd, J = 17.9,
3.6 Hz, 1H), 3.38 (dd, J = 17.9, 8.7 Hz, 1H), 1.50
(d, J = 6.8 Hz, 3H), 1.45 (d, J =
6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ
196.17, 168.33, 150.65, 145.67, 140.75, 132.63, 131.63, 129.23, 128.53,
124.07, 123.47, 122.53, 55.65, 45.55, 43.72, 21.19, 20.53. HRMS (ESI)
calcd for C19H19N2O4 [M
+ H]+ 339.1339, found 339.1339.

3-(2-(4-Nitrophenyl)-2-oxoethyl)-2-phenylisoindolin-1-one
(3m)
White solid (64.7 mg, 87%), mp = 153–155
°C. 1H NMR (400 MHz, CDCl3) δ 8.26
(d, J = 8.8 Hz, 2H), 7.97 (dd, J = 13.0, 5.2 Hz, 3H), 7.81–7.34 (m, 7H), 7.23 (t, J = 7.4 Hz, 1H), 5.97 (dd, J = 9.1, 3.0
Hz, 1H), 3.58 (dd, J = 17.9, 3.2 Hz, 1H), 3.26 (dd, J = 17.9, 9.1 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 196.32, 166.79, 150.64, 144.67, 140.55, 136.47,
132.51, 131.89, 129.46, 129.14, 129.03, 125.89, 124.40, 123.94, 123.35,
122.93, 56.79, 42.57. HRMS (ESI) calcd for C22H17N2O4 [M + H]+ 373.1183, found 373.1185.

3-(2-(4-Nitrophenyl)-2-oxoethyl)-2-(p-tolyl)isoindolin-1-one
(3n)
White solid (64.8 mg, 84%), mp = 161–162
°C. 1H NMR (400 MHz, CDCl3) δ 8.24
(d, J = 8.8 Hz, 2H), 7.95 (dd, J = 18.9, 7.6 Hz, 3H), 7.57–7.40 (m, 5H), 7.22 (d, J = 8.1 Hz, 2H), 5.90 (dd, J = 9.0, 3.1
Hz, 1H), 3.56 (dd, J = 17.8, 3.3 Hz, 1H), 3.24 (dd, J = 17.8, 9.1 Hz, 1H), 2.33 (s, 3H). 13C NMR
(100 MHz, CDCl3) δ 196.38, 166.74, 150.58, 144.70,
140.58, 135.87, 133.79, 132.35, 131.99, 130.01, 129.15, 128.95, 124.27,
123.89, 123.58, 122.93, 57.01, 42.54, 20.97. HRMS (ESI) calcd for
C23H19N2O4 [M + H]+ 387.1339, found 387.1340.

2-(4-Chlorobenzyl)-3-(2-(4-nitrophenyl)-2-oxoethyl)isoindolin-1-one
(3o)
White solid (71.4 mg, 85%), mp = 165–166
°C. 1H NMR (400 MHz, CDCl3) δ 8.25
(d, J = 8.7 Hz, 2H), 7.93 (d, J =
6.7 Hz, 1H), 7.86 (d, J = 8.7 Hz, 2H), 7.61–7.46
(m, 2H), 7.39 (d, J = 7.1 Hz, 1H), 7.12 (q, J = 8.4 Hz, 4H), 5.30 (t, J = 5.9 Hz, 1H),
4.76 (s, 2H), 3.41 (dd, J = 17.9, 6.5 Hz, 1H), 3.22
(dd, J = 17.9, 5.4 Hz, 1H). 13C NMR (100
MHz, CDCl3) δ 195.39, 168.66, 150.60, 145.24, 140.13,
135.71, 133.44, 132.17, 131.58, 129.31, 128.98, 128.83, 124.20, 123.86,
122.40, 55.96, 44.55, 43.11. HRMS (ESI) calcd for C23H18ClN2O4 [M + H]+ 421.0950,
found 421.0952.

2-(4-Fluorobenzyl)-3-(2-(4-nitrophenyl)-2-oxoethyl)isoindolin-1-one
(3p)
White solid (67.1 mg, 82%), mp = 171–173
°C. 1H NMR (400 MHz, CDCl3) δ 8.26
(d, J = 8.8 Hz, 2H), 8.00–7.81 (m, 3H), 7.59–7.45
(m, 2H), 7.38 (d, J = 7.3 Hz, 1H), 7.21 (dd, J = 8.3, 5.5 Hz, 2H), 6.87 (t, J = 8.6
Hz, 2H), 5.27 (t, J = 6.0 Hz, 1H), 4.88 (d, J = 15.4 Hz, 1H), 4.65 (d, J = 15.4 Hz,
1H), 3.45 (dd, J = 18.0, 6.1 Hz, 1H), 3.24 (dd, J = 18.0, 6.0 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 195.52, 168.58, 161.643 (d, J =
245 Hz), 150.61, 145.28, 140.32, 132.94 (d, J = 3.1
Hz), 132.11, 131.65, 129.63 (d, J = 8.0 Hz), 129.02,
128.79, 124.14, 123.89, 122.49, 115.69, 115.47, 55.74, 44.29, 42.99.
HRMS (ESI) calcd for C23H18FN2O4 [M + H]+ 405.1245, found 4051245.

2-(4-Methylbenzyl)-3-(2-(4-nitrophenyl)-2-oxoethyl)isoindolin-1-one
(3q)
White solid (69.6 mg, 87%), mp = 163–165
°C. 1H NMR (400 MHz, CDCl3) δ 8.22
(d, J = 8.7 Hz, 2H), 7.93 (dd, J = 5.4, 2.9 Hz, 1H), 7.85 (d, J = 8.7 Hz, 2H), 7.57–7.46
(m, 2H), 7.43–7.33 (m, 1H), 7.09 (d, J = 7.8
Hz, 2H), 6.96 (d, J = 7.8 Hz, 2H), 5.26 (t, J = 6.0 Hz, 1H), 4.82 (d, J = 15.4 Hz,
1H), 4.70 (d, J = 15.4 Hz, 1H), 3.47 (dd, J = 17.8, 5.9 Hz, 1H), 3.16 (dd, J = 17.8,
6.2 Hz, 1H), 2.18 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 195.52, 168.50, 150.47, 145.32, 140.39, 137.25, 133.94,
131.93, 131.86, 129.36, 129.04, 128.69, 127.93, 124.10, 123.71, 122.45,
55.86, 44.76, 42.83, 20.95. HRMS (ESI) calcd for C24H21N2O4 [M + H]+ 401.1496,
found 401.1497.

2-(4-Chlorophenethyl)-3-(2-(4-nitrophenyl)-2-oxoethyl)isoindolin-1-one
(3r)
White solid (76.4 mg, 88%), mp = 132–134
°C. 1H NMR (400 MHz, CDCl3) δ 8.32
(d, J = 8.8 Hz, 2H), 8.01 (d, J =
8.8 Hz, 2H), 7.85 (d, J = 6.7 Hz, 1H), 7.49 (tt, J = 13.0, 6.7 Hz, 2H), 7.37 (d, J = 7.2
Hz, 1H), 7.18 (q, J = 8.4 Hz, 4H), 5.21 (t, J = 6.0 Hz, 1H), 4.10–3.94 (m, 1H), 3.56–3.40
(m, 1H), 3.22–2.93 (m, 4H). 13C NMR (100 MHz, CDCl3) δ 195.88, 168.57, 150.70, 145.28, 140.35, 137.54,
132.42, 131.92, 130.46, 129.18, 128.75, 128.70, 124.09, 123.74, 122.60,
55.79, 43.15, 42.88, 33.75. HRMS (ESI) calcd for C24H20ClN2O4 [M + H]+ 435.1106,
found 435.1105.

2-Benzyl-3-(2,4,6-trimethoxyphenyl)isoindolin-1-one
(5a)21
White solid
(71.6 mg, 92%),
mp = 102–104 °C. 1H NMR (400 MHz, CDCl3) δ 7.88 (dd, J = 5.1, 3.4 Hz, 1H),
7.44–7.31 (m, 2H), 7.25–6.99 (m, 6H), 6.16 (d, J = 2.0 Hz, 1H), 5.99 (s, 1H), 5.92 (d, J = 2.0 Hz, 1H), 5.14 (d, J = 14.7 Hz, 1H), 3.83
(d, J = 14.8 Hz, 1H), 3.80 (s, 3H), 3.70 (s, 3H),
3.25 (s, 3H). 13C NMR (126 MHz, CDCl3) δ
168.91, 161.69, 160.50, 160.14, 146.98, 137.91, 132.95, 130.86, 128.56,
128.12, 127.10, 126.99, 122.96, 121.83, 103.99, 91.24, 90.44, 55.79,
55.41, 55.32, 54.73, 44.15. HRMS (ESI) calcd for C24H24NO4 [M + H]+ 390.1700, found 390.1700.

2-Benzyl-3-mesitylisoindolin-1-one (5b)
White
solid (61.4 mg, 90%), mp = 132–134 °C. 1H NMR
(400 MHz, CDCl3) δ 8.04–7.85 (m, 1H),
7.53–7.36 (m, 2H), 7.26 (q, J = 6.0 Hz, 3H),
7.16–7.03 (m, 3H), 6.90 (s, 1H), 6.73 (s, 1H), 5.75 (s, 1H),
5.44 (d, J = 14.6 Hz, 1H), 3.60 (d, J = 14.7 Hz, 1H), 2.28 (s, 3H), 2.04 (s, 3H), 1.57 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 168.58, 145.15, 138.12,
138.08, 138.03, 137.24, 132.59, 131.80, 131.44, 129.68, 128.68, 128.52,
128.22, 128.01, 127.58, 123.67, 122.37, 59.29, 43.79, 20.89, 20.61,
18.53. HRMS (ESI) calcd for C24H24NO [M + H]+ 342.1852, found 342.1853.

2-Benzyl-3-(5-methylthiophen-2-yl)isoindolin-1-one
(5c)21
White solid
(58.3 mg, 91%),
mp = 206–207 °C. 1H NMR (400 MHz, CDCl3) δ 7.91 (dd, J = 5.7, 2.8 Hz, 1H),
7.53–7.39 (m, 2H), 7.27 (dt, J = 12.0, 7.2
Hz, 6H), 6.83 (d, J = 3.3 Hz, 1H), 6.72–6.33
(m, 1H), 5.47 (s, 1H), 5.38 (d, J = 14.9 Hz, 1H),
3.90 (d, J = 14.9 Hz, 1H), 2.42 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 167.77, 145.78, 141.60,
137.51, 137.21, 131.91, 131.25, 128.74, 128.65, 128.55, 128.50, 127.92,
127.58, 124.89, 123.74, 123.25, 59.07, 43.61, 15.54. HRMS (ESI) calcd
for C20H18NOS [M + H]+ 320.1104,
found 320.1105.

5,12b-Dihydroisoindolo[1,2-a]isoquinolin-8(6H)-one (6a)27
White solid (41.8 mg, 89%), mp = 114–116
°C. 1H NMR (400 MHz, CDCl3) δ 7.87
(dd, J = 7.5, 2.7 Hz, 2H), 7.68–7.56 (m, 2H),
7.49 (t, J = 7.5 Hz, 1H), 7.33–7.15 (m, 3H),
5.67 (s, 1H), 4.43 (dt, J = 12.7, 5.2 Hz, 1H), 3.59–3.38
(m, 1H), 3.07 (ddd, J = 15.5, 9.1, 6.1 Hz, 1H), 2.88
(dt, J = 15.9, 4.5 Hz, 1H). 13C NMR (100
MHz, CDCl3) δ 167.94, 144.25, 134.82, 134.37, 132.87,
131.52, 129.32,
128.50, 127.46, 126.72, 125.24, 123.88, 123.49, 59.15, 38.21, 29.45.
HRMS (ESI) calcd for C16H14NO [M + H]+ 236.1070, found 236.1070.

2-Methyl-5,12b-dihydroisoindolo[1,2-a]isoquinolin-8(6H)-one (6b)
White solid (45.3 mg,
91%), mp = 102–103 °C. 1H NMR (400 MHz, CDCl3) δ 7.88 (dd, J = 7.5, 3.6 Hz, 2H),
7.62 (t, J = 7.5 Hz, 1H), 7.50 (t, J = 7.5 Hz, 1H), 7.42 (s, 1H), 7.07 (dd, J = 18.1,
7.7 Hz, 2H), 5.64 (s, 1H), 4.45–4.37 (m, 1H), 3.51–3.41
(m, 1H), 3.01 (dd, J = 9.1, 6.4 Hz, 1H), 2.88–2.79
(m, 1H), 2.37 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 167.96, 144.30, 136.35, 134.18, 132.87, 131.72, 131.49,
129.16, 128.46, 128.26, 125.77, 123.87, 123.50, 59.19, 38.37, 29.06,
21.26. HRMS (ESI) calcd for C17H16NO [M + H]+ 250.1226, found 250.1226.

2-Methoxy-5,12b-dihydroisoindolo[1,2-a]isoquinolin-8(6H)-one (6c)28
White solid (46.1 mg, 87%),
mp = 102–103 °C. 1H NMR (400 MHz, CDCl3) δ 7.87 (t, J = 7.9 Hz, 2H), 7.61
(t, J = 7.5 Hz, 1H), 7.50 (t, J =
7.5 Hz, 1H), 7.14 (dd, J = 15.6, 5.1
Hz, 2H), 6.80 (dd, J = 8.3, 2.2 Hz, 1H), 5.64 (s,
1H), 4.41 (dt, J = 12.6, 5.1 Hz, 1H), 3.82 (s, 3H),
3.53–3.41 (m, 1H), 3.01 (ddd, J = 15.3, 9.2,
6.0 Hz, 1H), 2.83 (dt, J = 15.5, 4.5 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 167.94, 158.32,
144.09, 135.40, 132.89, 131.55, 130.12, 128.53, 126.84, 123.91, 123.39,
112.55, 111.47, 59.23, 55.43, 38.48, 28.58. HRMS (ESI) calcd for C17H16NO2 [M + H]+ 266.1176,
found 266.1176.

5-Phenyl-5,12b-dihydroisoindolo[1,2-a]isoquinolin-8(6H)-one (6d)
White solid (51.0 mg,
82%), mp = 178–180 °C. 1H NMR (400 MHz, CDCl3) δ 7.90 (t, J = 7.3 Hz, 2H), 7.74
(d, J = 7.8 Hz, 1H), 7.60 (t, J =
7.5 Hz, 1H), 7.48 (t, J = 7.5 Hz, 1H), 7.39–7.18
(m, 6H), 7.11 (t, J = 7.5 Hz, 1H), 6.85 (d, J = 7.8 Hz, 1H), 5.83 (s, 1H), 4.74 (dd, J = 13.2, 5.9 Hz, 1H), 4.25 (dd, J = 10.5, 6.0 Hz,
1H), 3.47 (dd, J = 13.0, 10.9 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 167.80, 144.94, 141.60,
138.22, 134.39, 132.62, 131.80, 130.17, 129.10, 128.85, 128.58, 127.37,
127.24, 126.86, 125.42, 123.95, 123.46, 59.56, 45.79, 45.18. HRMS
(ESI) calcd for C16H13ClNO [M + H]+ 270.0680, found 270.0681.

2-Benzyl-3-methoxyisoindolin-1-one
(8a)
Colorless oil (46.6 mg, 92%). 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 7.1 Hz, 1H), 7.60–7.45
(m, 3H), 7.40–7.21 (m, 5H), 5.71 (s, 1H), 5.19 (d, J = 14.7 Hz, 1H), 4.21 (d, J = 14.7 Hz,
1H), 2.88 (s, 3H). 13C NMR (100 MHz, CDCl3)
δ 167.48, 140.47, 136.87, 132.99, 132.10, 129.97, 128.72, 128.65,
128.63, 127.65, 123.68, 123.51, 85.64, 49.36, 43.15. HRMS (ESI) calcd
for C16H16NO2 [M + H]+ 254.1176, found 254.1175.

2-Benzyl-3-ethoxyisoindolin-1-one
(8b)
Colorless oil (47.5 mg, 89%). 1H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 7.1 Hz, 1H), 7.60–7.45
(m, 3H), 7.31 (ddd, J = 22.6, 16.7, 6.9 Hz, 5H),
5.71 (s, 1H), 5.15 (d, J = 14.7 Hz, 1H), 4.27 (d, J = 14.7 Hz, 1H), 3.15 (dq, J = 14.2, 7.1
Hz, 1H), 2.99 (dd, J = 15.9, 7.1 Hz, 1H), 1.09 (t, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.38, 141.19, 137.00, 132.76, 132.03, 129.83, 128.70,
128.62, 128.59, 127.62, 123.63, 123.40, 85.56, 58.03, 43.33, 15.05.
HRMS (ESI) calcd for C17H18NO2 [M
+ H]+ 268.1332, found 268.1332.

2-Benzyl-3-butoxyisoindolin-1-one
(8c)
Colorless oil (51.9 mg, 88%). 1H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 7.1 Hz, 1H), 7.59–7.45
(m, 3H), 7.31 (ddd, J = 29.7, 15.5, 7.1 Hz, 5H),
5.71 (s, 1H), 5.17 (d, J = 14.7 Hz, 1H), 4.24 (d, J = 14.7 Hz, 1H), 3.09 (dd, J = 15.3, 6.5
Hz, 1H), 2.92 (dd, J = 15.3, 6.6 Hz, 1H), 1.45 (dq, J = 13.1, 6.5 Hz, 2H), 1.31 (dq, J = 15.1,
7.4 Hz, 2H), 0.86 (t, J = 7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.38, 141.20, 136.98,
132.80, 132.01, 129.81, 128.70, 128.62, 127.61, 123.62, 123.40, 85.43,
62.14, 43.26, 31.63, 19.35, 13.84. HRMS (ESI) calcd for C19H22NO2 [M + H]+ 296.1645, found
296.1645.

2-Benzyl-3-(heptyloxy)isoindolin-1-one (8d)
Colorless oil (57.3 mg, 85%). 1H NMR
(400 MHz, CDCl3) δ 7.85 (d, J =
7.1 Hz, 1H), 7.50
(ddd, J = 20.8, 13.7, 6.9 Hz, 3H), 7.37 (d, J = 7.2 Hz, 2H), 7.30 (t, J = 7.3 Hz, 2H),
7.26–7.22 (m, 1H), 5.70 (s, 1H), 5.16 (d, J = 14.7 Hz, 1H), 4.25 (d, J = 14.7 Hz, 1H), 3.08
(dd, J = 15.3, 6.6 Hz, 1H), 2.91 (dd, J = 15.4, 6.6 Hz, 1H), 1.45 (dd, J = 10.6, 6.1 Hz,
2H), 1.23 (s, 8H), 0.87 (t, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.35, 141.24,
137.03, 132.81, 132.00, 129.80, 128.81–128.51, 127.61, 123.61,
123.41, 85.49, 62.45, 43.31, 31.78, 29.56, 29.05, 26.13, 22.61, 14.11.
HRMS (ESI) calcd for C22H28NO2 [M
+ H]+ 338.2115, found 338.2115.

2-Benzyl-3-cyclobutoxyisoindolin-1-one
(8e)
Colorless oil (52.2 mg, 89%). 1H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 6.4 Hz, 1H), 7.56–7.44
(m, 3H), 7.29 (ddd, J = 22.7, 13.7, 7.0 Hz, 5H),
5.63 (s, 1H), 5.17 (d, J = 14.7 Hz, 1H), 4.22 (d, J = 14.8 Hz, 1H), 3.67 (dd, J = 15.1, 7.6
Hz, 1H), 2.00 (dd, J = 16.5, 8.2 Hz, 2H), 1.86 (dd, J = 19.1, 10.1 Hz, 1H), 1.59 (dtd, J =
15.3, 10.4, 6.2 Hz, 2H), 1.29–1.19 (m, 1H). 13C
NMR (100 MHz, CDCl3) δ 167.37, 141.80, 137.00, 132.53,
131.88, 129.80, 128.71, 128.58, 128.55, 127.61, 123.75, 123.51, 84.88,
67.47, 43.19, 32.45, 31.58, 12.84. HRMS (ESI) calcd for C19H22NO2 [M + H]+ 296.1645, found
296.1645.

2-Benzyl-3-(cyclopentyloxy)isoindolin-1-one
(8f)
Colorless oil (53.4 mg, 87%). 1H NMR (400 MHz,
CDCl3) δ 7.85 (d, J = 7.1 Hz, 1H),
7.51 (ddd, J = 17.5, 11.9, 7.1 Hz, 3H), 7.37–7.22
(m, 5H), 5.64 (s, 1H), 5.25 (d, J = 14.9 Hz, 1H),
4.24 (d, J = 14.9 Hz, 1H), 3.92–3.70 (m, 1H),
1.76–1.62 (m, 4H), 1.45 (ddt, J = 15.2, 12.3,
7.7 Hz, 4H). 13C NMR (100 MHz, CDCl3) δ
167.41, 142.31, 137.08, 132.50, 131.93, 129.73, 128.74, 128.37, 128.35,
128.32, 127.59, 123.75, 123.56, 85.38, 77.06, 43.23, 33.72, 33.50,
23.32, 23.22. HRMS (ESI) calcd for C20H22NO2 [M + H]+ 308.1645, found 308.1645.

2-Benzyl-3-(isopentyloxy)isoindolin-1-one
(8g)
Colorless oil (54.4 mg, 88%). 1H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 7.2 Hz, 1H), 7.57–7.44
(m, 3H), 7.37 (d, J = 7.2 Hz, 2H), 7.31 (t, J = 7.3 Hz, 2H), 7.27–7.23 (m, 1H), 5.71 (s, 1H),
5.16 (d, J = 14.6 Hz, 1H), 4.26 (d, J = 14.7 Hz, 1H), 3.19–3.04 (m, 1H), 2.93 (dd, J = 15.7, 6.9 Hz, 1H), 1.64 (dt, J = 13.4, 6.7 Hz,
1H), 1.35 (ddt, J = 20.4, 13.7, 6.8 Hz, 2H), 0.82
(dd, J = 14.3, 6.6 Hz, 6H). 13C NMR (100
MHz, CDCl3) δ 141.21, 137.01, 132.79, 132.03, 129.83,
129.79, 128.71, 128.68, 128.61, 127.62, 123.62, 123.38, 85.51, 60.77,
43.33, 38.42, 24.90. HRMS (ESI) calcd for C20H24NO2 [M + H]+ 310.1802, found 310.1803.

2-Benzyl-3-(3-methoxypropoxy)isoindolin-1-one
(8h)
Colorless oil (52.3 mg, 88%). 1H NMR (400 MHz,
CDCl3) δ 7.86 (d, J = 7.2 Hz, 1H),
7.57–7.44 (m, 3H), 7.31 (ddd, J = 23.7, 17.1,
7.0 Hz, 5H), 5.70 (s, 1H), 5.17 (d, J = 14.7 Hz,
1H), 4.24 (d, J = 14.7 Hz, 1H), 3.39 (dt, J = 9.0, 4.6 Hz, 2H), 3.29 (s, 3H), 3.24–3.17 (m,
1H), 3.07–2.97 (m, 1H), 1.77–1.69 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 167.35, 141.08, 137.00,
132.76, 132.06, 129.87, 128.73, 128.63, 128.61, 127.71, 127.64, 123.65,
123.42, 85.43, 69.32, 59.47, 58.60, 43.23, 29.72. HRMS (ESI) calcd
for C19H22NO3 [M + H]+ 312.1594, found 312.1594.

2-Benzyl-3-(benzyloxy)isoindolin-1-one
(8i)
Colorless oil (55.6 mg, 90%). 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 6.4 Hz, 1H), 7.55–7.45
(m, 3H), 7.36 (d, J = 7.1 Hz, 2H), 7.33–7.22
(m, 6H), 7.17 (d, J = 7.0 Hz, 2H), 5.84 (s, 1H),
5.16 (d, J = 14.7 Hz, 1H), 4.28 (d, J = 14.7 Hz, 1H), 4.10 (d, J = 11.2 Hz, 1H), 3.99
(d, J = 11.1 Hz, 1H). 13C NMR (100 MHz,
CDCl3) δ 167.47, 140.93, 137.33, 136.94, 132.84,
132.26, 130.09, 128.81, 128.71, 128.52, 127.94, 127.88, 127.74, 123.77,
123.64, 85.67, 64.77, 43.52. HRMS (ESI) calcd for C22H20NO2 [M + H]+ 330.1489, found 330.1490.

2-Benzyl-3-phenethoxyisoindolin-1-one (8j)
Colorless oil (62.4 mg, 91%). 1H NMR (400 MHz, CDCl3) δ 7.88–7.79 (m, 1H), 7.52–7.44 (m, 2H),
7.34–7.19 (m, 9H), 7.12 (d, J = 7.2 Hz, 2H),
5.66 (s, 1H), 4.98 (d, J = 14.7 Hz, 1H), 3.87 (d, J = 14.7 Hz, 1H), 3.25 (dd, J = 15.7, 7.1
Hz, 1H), 3.18–3.07 (m, 1H), 2.72 (t, J = 6.5
Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 167.37,
140.83, 138.80, 137.00, 132.77, 132.05, 129.89, 129.11, 128.69, 128.62,
128.43, 127.60, 126.48, 123.66, 123.48, 85.39, 63.15, 43.03, 36.05.
HRMS (ESI) calcd for C23H22NO2 [M
+ H]+ 344.4645, found 344.1645.

2-Benzyl-3-(p-tolyloxy)isoindolin-1-one (8k)
Colorless oil
(61.7 mg, 90%). 1H NMR
(400 MHz, CDCl3) δ 7.89 (d, J =
6.5 Hz, 1H), 7.59–7.47 (m, 3H), 7.36 (d, J = 7.0 Hz, 2H), 7.27 (dt, J = 20.3, 7.2 Hz, 3H),
7.10 (dd, J = 20.4, 7.9 Hz, 4H), 5.83 (s, 1H), 5.17
(d, J = 14.7 Hz, 1H), 4.27 (d, J = 14.7 Hz, 1H), 4.02 (dd, J = 42.6, 10.9 Hz, 2H),
2.32 (s, 3H). 13C NMR (100 MHz, CDCl3) δ
167.47, 141.02, 137.70, 136.94, 134.25, 132.83, 132.22, 130.02, 129.20,
128.78, 128.71, 128.01, 127.70, 123.75, 123.62, 85.58, 64.75, 43.46,
21.23. HRMS (ESI) calcd for C22H20NO2 [M + H]+ 330.1489, found 330.1490.

3-(Benzhydryloxy)-2-benzylisoindolin-1-one
(8l)
Colorless oil (73.7 mg, 91%). 1H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 7.5 Hz, 1H), 7.41
(t, J = 7.5 Hz, 1H), 7.33–7.14 (m, 16H), 7.01
(d, J = 7.5 Hz, 1H), 5.84 (s, 1H), 5.29 (s, 1H),
5.04 (d, J = 15.1 Hz, 1H), 3.81 (d, J = 15.1 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ
167.50, 142.40, 140.39, 141.43, 136.98, 132.45, 131.83, 129.81, 128.78,
128.73, 128.39, 128.32, 128.30, 127.87, 127.65, 127.43, 137.31, 126.71,
124.05, 123.46, 85.51, 78.93, 43.11. HRMS (ESI) calcd for C28H24NO2 [M + H]+ 406.1802, found
406.1803.

3-Ethoxy-2-(4-fluorobenzyl)isoindolin-1-one
(8m)
Colorless oil (53.0 mg, 93%). 1H NMR (400 MHz,
CDCl3) δ 7.86 (d, J = 7.3 Hz, 1H),
7.53 (ddd, J = 10.6, 10.0, 5.4 Hz, 3H), 7.37 (dd, J = 8.3, 5.5 Hz, 2H), 7.00 (t, J = 8.6
Hz, 2H), 5.71 (s, 1H), 5.07 (d, J = 14.7 Hz, 1H),
4.28 (d, J = 14.7 Hz, 1H), 3.19–3.05 (m, 1H),
3.04–2.92 (m, 1H), 1.09 (t, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.35, 162.28
(d, J = 245 Hz), 141.08, 132.86 (d, J = 3.1 Hz), 132.64, 132.12, 130.39, 130.37, 130.34, 130.31, 129.89,
123.53 (d, J = 22 Hz), 123.42, 115.63, 115.42, 85.58,
57.96, 42.66, 15.01. HRMS (ESI) calcd for C17H17FNO2 [M + H]+ 286.1238, found 286.1239.

3-Ethoxy-2-(4-methylbenzyl)isoindolin-1-one
(8n)
Colorless oil (48.9 mg, 87%). 1H NMR (400 MHz,
CDCl3) δ 7.85 (d, J = 7.1 Hz, 1H),
7.52 (ddd, J = 19.0, 12.7, 6.8 Hz, 3H), 7.27 (d, J = 7.9 Hz, 2H), 7.12 (d, J = 7.8 Hz, 2H),
5.70 (s, 1H), 5.13 (d, J = 14.6 Hz, 1H), 4.20 (d, J = 14.6 Hz, 1H), 3.25–2.89 (m, 2H), 2.31 (s, 3H),
1.10 (t, J = 7.0 Hz, 3H). 13C NMR (100
MHz, CDCl3) δ 167.32, 141.22, 137.28, 133.95, 132.83,
131.97, 129.78, 129.35, 128.62, 123.58, 123.36, 85.43, 58.03, 43.00,
21.11, 15.09. HRMS (ESI) calcd for C18H20NO2 [M + H]+ 282.1489, found 282.1490.

3-Ethoxy-2-(p-tolyl)isoindolin-1-one (8o)
Colorless
oil (45.4 mg, 85%). 1H NMR
(400 MHz, CDCl3) δ 7.90 (d, J =
7.4 Hz, 1H), 7.73–7.48 (m, 5H), 6.98 (d, J = 9.0 Hz, 2H), 6.35 (s, 1H), 3.83 (s, 3H), 3.27 (dd, J = 8.8, 7.2 Hz, 1H), 3.03 (dd, J = 8.8, 7.2 Hz,
1H), 1.04 (t, J = 7.0 Hz, 3H). 13C NMR
(100 MHz, CDCl3) δ 166.60, 157.32, 140.57, 132.81,
132.51, 130.35, 130.10, 124.00, 123.78, 123.30, 114.35, 87.64, 58.01,
55.47, 15.00. HRMS (ESI) calcd for C17H18NO2 [M + H]+ 268.1332, found 268.1333.

3-Ethoxy-2-phenylisoindolin-1-one
(8p)
Colorless oil (42.5 mg, 84%). 1H NMR (400 MHz, CDCl3) δ 7.91 (d, J = 7.5 Hz, 1H), 7.84
(d, J = 7.7 Hz, 2H), 7.69–7.55 (m, 3H), 7.44
(t, J = 8.0 Hz, 2H), 7.27–7.22 (m, 1H), 6.47
(s, 1H), 3.23 (dt, J = 14.1, 7.1 Hz, 1H), 3.02 (dq, J = 14.2, 7.1 Hz, 1H), 1.03 (t, J = 7.0
Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 166.66,
140.49, 137.50, 132.73, 130.19, 129.07, 125.26, 123.89, 123.33, 121.77,
87.13, 57.68, 14.96. HRMS (ESI) calcd for C16H16NO2 [M + H]+ 254.1176, found 254.1178.

2-(4-Chlorophenethyl)-3-ethoxyisoindolin-1-one
(8q)
Colorless oil (53.6 mg, 85%). 1H NMR (400 MHz,
CDCl3) δ 7.82 (d, J = 7.2 Hz, 1H),
7.54 (dt, J = 23.4, 6.9 Hz, 3H), 7.27–7.14
(m, 4H), 5.66 (s, 1H), 4.11–3.92 (m, 1H), 3.57–3.39
(m, 1H), 3.10 (dd, J = 15.1, 8.0 Hz, 1H), 3.07–2.87
(m, 3H), 1.11 (t, J = 7.0 Hz, 3H). 13C
NMR (100 MHz, CDCl3) δ 167.57, 140.98, 137.25, 132.79,
132.34, 132.00, 130.13, 129.87, 128.73, 123.44, 123.36, 86.35, 57.74,
40.84, 33.83, 15.07. HRMS (ESI) calcd for C18H19ClNO2 [M + H]+ 316.1099, found 316.1099.

2-(4-Chlorophenyl)-3-ethoxyisoindolin-1-one (8r)
Colorless oil (49.9 mg, 87%). 1H NMR (400 MHz,
CDCl3) δ 7.86 (dd, J = 17.9, 8.2
Hz, 3H), 7.71–7.51 (m, 3H), 7.38 (d, J = 8.8
Hz, 2H), 6.41 (s, 1H), 3.29–2.86 (m, 2H), 1.02 (t, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 166.53, 140.25, 136.21, 132.95, 132.47, 130.29, 130.24,
129.07, 123.91, 123.35, 122.42, 122.39, 86.94, 57.58, 14.94. HRMS
(ESI) calcd for C16H15ClNO2 [M +
H]+ 288.0786, found 288.0786.

2-Benzyl-3-(3-chloropropoxy)isoindolin-1-one
(8s)
Colorless oil (57.3 mg, 91%). 1H NMR (400 MHz,
CDCl3) δ 7.86 (d, J = 7.2 Hz, 1H),
7.58–7.45 (m, 3H), 7.38–7.23 (m, 5H), 5.71 (s, 1H),
5.15 (d, J = 14.7 Hz, 1H), 4.29 (d, J = 14.7 Hz, 1H), 3.59 (t, J = 6.3 Hz, 2H), 3.24
(dt, J = 9.3, 5.8 Hz, 1H), 3.08–2.99 (m, 1H),
1.86 (dd, J = 11.7, 5.6 Hz, 2H). 13C NMR
(100 MHz, CDCl3) δ 167.35, 140.79, 136.95, 132.71,
132.20, 130.01, 128.76, 128.60, 127.70, 123.72, 123.44, 85.48, 58.60,
43.42, 41.51, 32.21. HRMS (ESI) calcd for C18H19ClNO2 [M + H]+ 316.1099, found 316.1097.

2-Benzyl-3-(ethylthio)isoindolin-1-one (10a)
Colorless oil (52.1 mg, 92%). 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 7.5 Hz, 1H), 7.57
(s, 2H), 7.51–7.44 (m, 1H), 7.30 (dq, J =
13.7, 7.3 Hz, 5H), 5.38 (d, J = 14.7 Hz, 1H), 5.28
(s, 1H), 4.39 (d, J = 14.7 Hz, 1H), 1.96 (dd, J = 12.3, 7.5 Hz, 1H), 1.87–1.79 (m, 1H), 0.96 (t, J = 7.5 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.33, 143.66, 136.91, 132.16, 131.95, 128.86, 128.79,
128.60, 127.67, 123.61, 123.56, 62.85, 42.85, 20.21, 14.14. HRMS (ESI)
calcd for C17H18NSO [M + H]+ 284.1104,
found 284.1102.

2-Isopropyl-3-(propylthio)isoindolin-1-one
(10b)
Colorless oil (54.1 mg, 91%). 1H NMR (400 MHz,
CDCl3) δ 7.78 (d, J = 7.5 Hz, 1H),
7.56 (t, J = 6.1 Hz, 2H), 7.45 (ddd, J = 8.0, 4.6, 3.6 Hz, 1H), 5.57 (s, 1H), 4.34 (dt, J = 13.8, 6.9 Hz, 1H), 2.00 (dt, J = 11.9, 7.4 Hz,
1H), 1.76 (dt, J = 11.9, 7.2 Hz, 1H), 1.52 (dd, J = 14.7, 6.9 Hz, 6H), 1.29 (dt, J = 14.3,
7.2 Hz, 2H), 0.79 (t, J = 7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.72, 143.71, 132.71,
131.75, 128.66, 123.17, 123.03, 63.23, 45.47, 27.85, 22.06, 20.52,
20.04, 13.59. HRMS (ESI) calcd for C14H20NOS
[M + H]+ 250.1260, found 250.1261.

2-Benzyl-3-(propylthio)isoindolin-1-one
(10c)
Colorless oil (56.0 mg, 90%). 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 7.5 Hz, 1H), 7.57
(d, J = 12.6 Hz, 2H), 7.52–7.43 (m, 1H), 7.29
(ddd, J = 22.2, 13.8, 6.9 Hz, 5H), 5.37 (d, J = 14.7 Hz, 1H), 5.27 (s, 1H), 4.39 (d, J = 14.7 Hz, 1H), 1.90 (dt, J = 12.3, 7.4 Hz, 1H),
1.82–1.69 (m, 1H), 1.28 (dt, J = 14.5, 7.2
Hz, 2H), 0.80 (t, J = 7.3 Hz, 3H). 13C
NMR (100 MHz, CDCl3) δ 167.35, 143.69, 136.91, 132.10,
131.95, 128.85, 128.78, 128.60, 127.66, 123.60, 123.52, 62.70, 42.85,
28.02, 22.36, 13.59. HRMS (ESI) calcd for C19H22NOS [M + H]+ 312.1417, found 312.1418.

2-Benzyl-3-(pentylthio)isoindolin-1-one
(10d)
Colorless oil (56.6 mg, 87%). 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 7.5 Hz, 1H), 7.57
(d, J = 5.1 Hz, 2H), 7.48 (dd, J = 9.0, 3.8 Hz, 1H), 7.37–7.23 (m, 5H), 5.37 (d, J = 14.7 Hz, 1H), 5.27 (s, 1H), 4.38 (d, J = 14.7
Hz, 1H), 1.92 (dt, J = 12.3, 7.3 Hz, 1H), 1.83–1.68
(m, 1H), 1.26 (d, J = 5.9 Hz, 2H), 1.20–1.10
(m, 4H), 0.79 (t, J = 6.7 Hz, 3H). 13C
NMR (100 MHz, CDCl3) δ 167.36, 143.70, 136.92, 132.09,
131.96, 128.84, 128.81, 128.78, 128.60, 127.66, 123.59, 123.52, 62.74,
42.85, 31.03, 28.59, 25.94, 22.06, 13.85. HRMS (ESI) calcd for C20H24NOS [M + H]+ 326.1573, found 326.1574.

2-Benzyl-3-(heptylthio)isoindolin-1-one (10e)
Colorless oil (60.0 mg, 85%). 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 7.5 Hz, 1H), 7.56
(d, J = 5.0 Hz, 2H), 7.51–7.42 (m, 1H), 7.29
(ddd, J = 22.5, 14.0, 7.1 Hz, 5H), 5.37 (d, J = 14.7 Hz, 1H), 5.27 (s, 1H), 4.38 (d, J = 14.7 Hz, 1H), 1.93 (dt, J = 12.4, 7.3 Hz, 1H),
1.83–1.72 (m, 1H), 1.19 (ddd, J = 30.5, 14.7,
7.1 Hz, 10H), 0.85 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.35, 143.70, 136.93,
132.08, 131.97, 128.83, 128.78, 128.60, 127.65, 123.59, 123.52, 62.75,
42.85, 31.57, 29.91, 29.82, 29.63, 25.97, 22.53, 14.06 (s). HRMS (ESI)
calcd for C22H28NOS [M + H]+ 354.1886,
found 354.1885.

2-Benzyl-3-(isopropylthio)isoindolin-1-one
(10f)
Colorless oil (54.6 mg, 92%). 1H NMR (400 MHz,
CDCl3) δ 7.88 (d, J = 7.5 Hz, 1H),
7.56 (t, J = 6.1 Hz, 2H), 7.52–7.44 (m, 1H),
7.28 (dq, J = 18.4, 7.0 Hz, 5H), 5.40 (d, J = 14.7 Hz, 1H), 5.31 (s, 1H), 4.42 (d, J = 14.7 Hz, 1H), 2.34 (dt, J = 13.6, 6.8 Hz, 1H),
1.11 (d, J = 6.8 Hz, 3H), 0.90 (d, J = 6.9 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ
167.25, 143.88, 136.92, 132.02, 131.79, 128.87, 128.81, 128.52, 127.66,
123.80, 123.66, 63.20, 42.88, 32.51, 24.92, 24.34. HRMS (ESI) calcd
for C18H20NOS [M + H]+ 298.1260,
found 298.1261.

2-Benzyl-3-(cyclopentylthio)isoindolin-1-one
(10g)
Colorless oil (59.4 mg, 92%). 1H NMR (400 MHz,
CDCl3) δ 7.88 (d, J = 7.5 Hz, 1H),
7.56 (dd, J = 7.0, 5.5 Hz, 2H), 7.50–7.39
(m, 1H), 7.38–7.16 (m, 5H), 5.39 (d, J = 14.7
Hz, 1H), 5.29 (s, 1H), 4.42 (d, J = 14.7 Hz, 1H),
2.32 (dd, J = 15.3, 7.8 Hz, 1H), 1.78–1.67
(m, 1H), 1.65–1.46 (m, 2H), 1.43–1.23 (m, 4H), 1.19–1.09
(m, 1H). 13C NMR (100 MHz, CDCl3) δ 167.28,
144.10, 136.94, 131.95, 131.76, 128.79, 128.75, 128.61, 128.58, 128.56,
127.65, 123.83, 123.63, 63.24, 42.90, 39.66, 34.56, 34.10, 24.72,
24.44. HRMS (ESI) calcd for C20H22NOS [M + H]+ 324.1417, found 324.1418.

2-Benzyl-3-(isobutylthio)isoindolin-1-one
(10h)
Colorless oil (54.1 mg, 87%). 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 7.5 Hz, 1H), 7.60–7.51
(m, 2H), 7.51–7.44 (m, 1H), 7.30 (ddd, J =
22.5, 13.9, 7.0 Hz, 5H), 5.37 (d, J = 14.7 Hz, 1H),
5.28 (s, 1H), 4.37 (d, J = 14.7 Hz, 1H), 1.80 (dd, J = 12.0, 6.7 Hz, 1H), 1.63 (dd, J = 11.9,
6.9 Hz, 1H), 1.46 (dt, J = 13.3, 6.7 Hz, 1H), 0.81
(t, J = 6.2 Hz, 6H). 13C NMR (100 MHz,
CDCl3) δ 167.39, 143.64, 136.91, 132.10, 131.98,
128.85, 128.81, 128.78, 128.61, 127.67, 123.59, 123.49, 62.59, 42.85,
34.60, 28.07, 22.14, 22.08. HRMS (ESI) calcd for C19H22NOS [M + H]+ 312.1417, found 312.1417.

2-Benzyl-3-(benzylthio)isoindolin-1-one
(10i)
Colorless oil (64.2 mg, 93%). 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 7.2 Hz, 1H), 7.55–7.45
(m, 3H), 7.33–7.24 (m, 5H), 7.21–7.12 (m, 3H), 6.95
(d, J = 6.9 Hz, 2H), 5.30 (s, 1H), 5.22 (d, J = 14.8 Hz, 1H), 4.26 (d, J = 14.8 Hz,
1H), 3.09 (d, J = 2.8 Hz, 2H). 13C NMR
(100 MHz, CDCl3) δ 167.25, 143.15, 137.04, 136.90,
132.22, 132.08, 129.02, 128.83, 128.80, 128.75, 128.61, 128.50, 127.70,
127.12, 123.68, 123.59, 63.24, 42.89, 31.29. HRMS (ESI) calcd for
C22H20NOS [M + H]+ 346.1260, found
346.1261.

2-Benzyl-3-((4-methylbenzyl)thio)isoindolin-1-one
(10j)
Colorless oil (67.5 mg, 94%). H NMR (400
MHz, CDCl3) δ 7.88 (d, J = 7.3 Hz,
1H), 7.50
(tt, J = 14.1, 7.3 Hz, 3H), 7.35–7.21 (m,
5H), 7.00 (d, J = 7.8 Hz, 2H), 6.84 (d, J = 7.9 Hz, 2H), 5.31–5.19 (m, 2H), 4.28 (d, J = 14.8 Hz, 1H), 3.12–3.00 (m, 2H), 2.27 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 167.28, 143.29, 136.95,
136.79, 133.82, 132.21, 132.08, 129.21, 128.97, 128.82, 128.70, 128.68,
128.65, 128.62, 127.69, 123.68, 123.58, 63.26, 42.92, 31.01, 21.13.
HRMS (ESI) calcd for C23H22NOS [M + H]+ 360.1417, found 360.1417.

2-Benzyl-3-((4-chlorobenzyl)thio)isoindolin-1-one
(10k)
Colorless oil (69.7 mg, 92%). 1H NMR (400 MHz,
CDCl3) δ 7.88 (d, J = 6.9 Hz, 1H),
7.53–7.43 (m, 3H), 7.33–7.24 (m, 5H), 7.13 (d, J = 8.3 Hz, 2H), 6.84 (d, J = 8.3 Hz, 2H),
5.30 (s, 1H), 5.23 (d, J = 14.8 Hz, 1H), 4.26 (d, J = 14.8 Hz, 1H), 3.05 (q, J = 13.3 Hz,
2H). 13C NMR (100 MHz, CDCl3) δ 167.25,
142.98, 136.78, 135.72, 132.86, 132.26, 131.98, 130.04, 129.08, 128.85,
128.62, 128.58, 128.57, 128.54, 127.75, 123.68, 123.62, 63.19, 42.97,
30.51. HRMS (ESI) calcd for C22H19ClNOS [M +
H]+ 380.0870, found 380.0872.

2-Benzyl-3-((4-(tert-butyl)benzyl)thio)isoindolin-1-one
(10l)
Colorless oil (73.1 mg, 90%). 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 6.9 Hz, 1H), 7.54–7.40 (m, 3H), 7.37–7.21 (m, 5H),
7.22–7.13 (m, 2H), 6.89 (d, J = 8.1 Hz, 2H),
5.27 (d, J = 15.7 Hz, 2H), 4.31 (d, J = 14.7 Hz, 1H), 3.08 (dd, J = 28.7, 12.9 Hz, 2H),
1.27 (s, 9H). 13C NMR (100 MHz, CDCl3) δ
167.33, 150.03, 143.31, 136.97, 133.84, 132.16, 132.03, 128.95, 128.84,
128.66, 128.64, 128.48, 127.70, 125.42, 123.69, 123.56, 63.25, 42.93,
34.49, 31.36, 30.84. HRMS (ESI) calcd for C26H28NOS [M + H]+ 402.1886, found 402.1886.

Ethyl 2-((2-Benzyl-3-oxoisoindolin-1-yl)thio)acetate
(10m)
Colorless oil (58.0 mg, 85%). 1H
NMR (400 MHz, CDCl3) δ 7.88 (d, J = 7.5 Hz, 1H), 7.67–7.44 (m, 3H), 7.37–7.16 (m, 5H),
5.35 (d, J = 16.0 Hz, 2H), 4.37 (d, J = 14.8 Hz, 1H), 3.98 (tdd, J = 10.8, 7.2, 3.6 Hz,
2H), 2.66 (q, J = 15.3 Hz, 2H), 1.16 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 169.40, 167.10, 142.13, 136.69, 132.26, 132.21, 129.28,
128.85, 128.57, 127.75, 123.77, 123.67, 62.69, 61.75, 42.89, 28.82,
13.95. HRMS (ESI) calcd for C19H20NO3S [M + H]+ 342.1158, found 342.1159.

4-((1-Oxo-3-(propylthio)isoindolin-2-yl)methyl)benzonitrile
(10n)
Colorless oil (58.6 mg, 91%). 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 7.6 Hz, 1H), 7.66–7.57 (m, 4H), 7.55–7.45 (m, 3H),
5.33 (d, J = 15.2 Hz, 1H), 5.29 (s, 1H), 4.53 (d, J = 15.1 Hz, 1H), 1.90–1.72 (m, 2H), 1.28 (dd, J = 14.6, 7.3 Hz, 2H), 0.80 (t, J = 7.3
Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.56,
143.45, 142.41, 132.59, 132.49, 131.44, 129.18, 129.11, 123.68, 118.56,
111.65, 63.05, 42.73, 28.02, 22.23, 13.53. HRMS (ESI) calcd for C19H19N2OS [M + H]+ 323.1213,
found 323.1213.

2-Phenyl-3-(propylthio)isoindolin-1-one (10o)
Colorless oil (48.1 mg, 85%). 1H
NMR (400 MHz, CDCl3) δ 7.92 (d, J = 7.6 Hz, 1H), 7.58
(ddt, J = 35.2, 28.4, 8.0 Hz, 7H), 7.27 (d, J = 8.4 Hz, 1H), 6.13 (s, 1H), 1.98 (dt, J = 12.2, 7.3 Hz, 1H), 1.82 (dt, J = 12.2, 7.4 Hz,
1H), 1.32–1.13 (m, 2H), 0.70 (t, J = 7.3 Hz,
3H). 13C NMR (100 MHz, CDCl3) δ 166.58,
143.07, 136.52, 132.66, 131.97, 129.16, 129.13, 128.97, 125.94, 124.09,
123.84, 123.77, 123.61, 64.68, 28.66, 22.19, 13.43. HRMS (ESI) calcd
for C17H18NOS [M + H]+ 284.1104,
found 284.1105.

3-(Propylthio)-2-(p-tolyl)isoindolin-1-one
(10p)
Colorless oil (48.1 mg, 85%). 1H NMR (400 MHz, CDCl3) δ 7.90 (d, J = 7.6 Hz, 1H), 7.66 (q, J = 7.7 Hz, 2H), 7.53 (t, J = 7.2 Hz, 1H), 7.46 (d, J = 8.9 Hz, 2H),
7.00 (d, J = 8.9 Hz, 2H), 6.03 (s, 1H), 3.84 (s,
3H), 2.00 (dt, J = 12.2, 7.3 Hz, 1H), 1.83 (dt, J = 12.2, 7.4 Hz, 1H), 1.33–1.11 (m, 2H), 0.72 (t, J = 7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 166.66, 157.85, 143.06, 132.46, 129.10, 126.07, 123.76,
123.59, 114.35, 65.41, 55.47, 28.77, 22.22, 13.47. HRMS (ESI) calcd
for C18H20NOS [M + H]+ 298.1260,
found 298.1262.

2-Phenethyl-3-(propylthio)isoindolin-1-one
(10q)
Colorless oil (54.1 mg, 87%). 1H NMR (400 MHz,
CDCl3) δ 1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 7.5 Hz, 1H), 7.62–7.50 (m, 2H), 7.50–7.39
(m, 1H), 7.29–7.13 (m, 5H), 5.20 (s, 1H), 4.22 (ddd, J = 14.1, 8.2, 6.3 Hz, 1H), 3.73–3.57 (m, 1H), 3.12–2.88
(m, 2H), 1.77 (dtd, J = 14.3, 12.3, 7.4 Hz, 2H),
1.24 (dt, J = 14.6, 7.3 Hz, 2H), 0.77 (t, J = 7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.50, 143.60, 138.75, 132.12, 131.95, 128.79, 128.77,
128.63, 126.56, 123.48, 123.26, 63.92, 40.84, 34.56, 28.07, 22.30,
13.54. HRMS (ESI) calcd for C19H22NOS [M + H]+ 312.1417, found 312.1418.

2-(4-Chlorophenethyl)-3-(propylthio)isoindolin-1-one
(10r)
Colorless oil (60.7 mg, 88%). 1H
NMR (400 MHz, CDCl3) δ 7.82 (d, J = 7.5 Hz, 1H), 7.58 (d, J = 4.8 Hz, 2H), 7.55–7.43
(m, 1H), 7.32–7.15 (m, 4H), 5.24 (s, 1H), 4.19 (ddd, J = 14.2, 8.2, 6.4 Hz, 1H), 3.76–3.42 (m, 1H), 3.11–2.80
(m, 2H), 1.77 (ddt, J = 45.9, 12.2, 7.4 Hz, 2H),
1.25 (dt, J = 14.6, 7.3 Hz, 2H), 0.77 (t, J = 7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.52, 143.48, 137.17, 132.37, 132.05, 131.98, 130.13,
128.87, 128.75, 123.52, 123.29, 63.86, 40.62, 33.86, 28.01, 22.27,
13.53. HRMS (ESI) calcd for C19H21ClNOS [M +
H]+ 346.1027, found 346.1028.

2-(4-Methoxybenzyl)-3-(propylthio)isoindolin-1-one
(10s)
Colorless oil (51.7 mg, 84%). 1H NMR (400 MHz,
CDCl3) δ 7.86 (d, J = 7.5 Hz, 1H),
7.62–7.52 (m, 2H), 7.5–7.41 (m, 1H), 7.28 (t, J = 6.4 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H),
5.31 (d, J = 14.5 Hz, 1H), 5.26 (s, 1H), 4.32 (d, J = 14.5 Hz, 1H), 3.77 (s, 3H), 1.83 (ddt, J = 53.5, 12.2, 7.4 Hz, 2H), 1.29 (dt, J = 14.4,
7.2 Hz, 2H), 0.81 (t, J = 7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.27, 159.13, 143.69,
132.04, 129.97, 129.07, 128.81, 123.55, 123.47, 114.13, 62.56, 55.28,
42.23, 27.97, 22.35, 13.57. HRMS (ESI) calcd for C19H22NO2S [M + H]+ 328.1366, found 328.1365.

2-(4-Methylphenethyl)-3-(propylthio)isoindolin-1-one (10t)
Colorless oil (53.3 mg, 82%). 1H
NMR (400 MHz, CDCl3) δ 7.82 (d, J = 7.5 Hz, 1H), 7.55 (s, 2H), 7.51–7.37 (m, 1H), 7.11 (dd, J = 25.2, 7.8 Hz, 4H), 5.23 (s, 1H), 4.20 (ddd, J = 14.1, 8.1, 6.4 Hz, 1H), 3.71–3.54 (m, 1H), 3.04–2.81
(m, 2H), 2.30 (s, 3H), 1.77 (ddt, J = 26.8, 12.3,
7.4 Hz, 2H), 1.24 (dt, J = 14.6, 7.3 Hz, 2H), 0.77
(t, J = 7.3 Hz, 3H). 13C NMR (100 MHz,
CDCl3) δ 167.48, 143.63, 136.03, 135.61, 132.16,
131.91, 129.31, 129.29, 128.77, 128.66, 128.63, 123.49, 123.25, 63.90,
40.89, 34.11, 28.07, 22.32, 21.06, 13.54. HRMS (ESI) calcd for C20H24NOS [M + H]+ 326.1573, found 326.1573.

2-Benzyl-3-thiomorpholinoisoindolin-1-one (12a)
White solid (61.6 mg, 95%), mp = 110–112 °C. 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 6.8 Hz, 1H), 7.55–7.45 (m, 2H), 7.43 (d, J = 7.1 Hz, 1H), 7.35–7.23 (m, 5H), 5.21 (d, J = 14.6 Hz, 1H), 4.91 (s, 1H), 4.31 (d, J = 14.6
Hz, 1H), 3.03–2.65 (m, 4H), 2.59 (d, J = 4.4
Hz, 4H). 13C NMR (100 MHz, CDCl3) δ 167.46,
142.07, 137.45, 132.72, 131.52, 129.15, 128.69, 128.44, 127.52, 123.82,
123.36, 78.71, 50.07, 43.62, 28.54. HRMS (ESI) calcd for C19H21N2OS [M + H]+ 325.1369, found
325.1370.

2-Benzyl-3-morpholinoisoindolin-1-one (12b)29
White solid (57.3
mg, 93%), mp = 130–131
°C. 1H NMR (400 MHz, CDCl3) δ 7.89
(d, J = 6.6 Hz, 1H), 7.48 (dt, J = 13.8, 6.5 Hz, 3H), 7.36–7.18 (m, 5H), 5.22 (d, J = 14.6 Hz, 1H), 4.96 (s, 1H), 4.34 (d, J = 14.6 Hz, 1H), 3.65 (t, J = 4.4 Hz, 4H), 2.73–2.55
(m, 2H), 2.52–2.27 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 167.44, 141.87, 137.44, 132.80, 131.43, 129.17,
128.67, 128.52, 127.51, 123.89, 123.49, 77.38, 67.34, 47.64, 43.61.
HRMS (ESI) calcd for C20H24NO2 [M
+ H]+ 326.1573, found 326.1574.

2-Benzyl-3-(benzylamino)isoindolin-1-one
(12c)
Colorless oil (59.0 mg, 90%). 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 7.3 Hz, 1H), 7.59–7.41
(m, 3H), 7.27 (tt, J = 10.6, 7.4 Hz, 8H), 7.15 (d, J = 7.1 Hz, 2H), 5.32 (s, 1H), 5.17 (d, J = 15.0 Hz, 1H), 4.34 (d, J = 15.0 Hz, 1H), 3.35
(d, J = 13.0 Hz, 1H), 3.24 (d, J = 13.0 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ
167.75, 143.31, 139.67, 137.42, 132.84, 131.89, 129.19, 128.85, 128.44,
128.29, 128.09, 128.09, 127.63, 127.20, 123.56, 123.22, 72.33, 45.60,
43.26. HRMS (ESI) calcd for C22H21N2O [M + H]+ 329.1648, found 329.1648.

2-Benzyl-3-((4-fluorobenzyl)amino)isoindolin-1-one (12d)
Colorless oil (56.1 mg, 81%). 1H
NMR (400 MHz,
CDCl3) δ 7.88 (d, J = 7.2 Hz, 1H),
7.57–7.44 (m, 3H), 7.37–7.20 (m, 5H), 7.08 (dd, J = 8.2, 5.7 Hz, 2H), 6.92 (t, J = 8.6
Hz, 2H), 5.33 (s, 1H), 5.13 (d, J = 15.0 Hz, 1H),
4.38 (d, J = 15.0 Hz, 1H), 3.31 (d, J = 13.0 Hz, 1H), 3.19 (d, J = 13.0 Hz, 1H), 2.16
(s, 1H). 13C NMR (100 MHz, CDCl3) δ 167.76,
161.98 (d, J = 244 Hz), 143.18, 137.40, 135.39 (d, J = 2.7 Hz), 132.79, 131.91, 129.62 (d, J = 7.9 Hz), 129.22, 128.86, 128.26, 128.22, 127.66, 123.57, 123.18,
115.26, 115.05, 72.38, 44.80, 43.37. HRMS (ESI) calcd for C22H20FN2O [M + H]+ 347.1154, found
347.1155.

2-Benzyl-3-((4-chlorobenzyl)amino)isoindolin-1-one
(12e)
Colorless oil (61.5 mg, 85%). 1H NMR (400 MHz,
CDCl3) δ 7.87 (d, J = 7.1 Hz, 1H),
7.57–7.43 (m, 3H), 7.39–7.15 (m, 7H), 7.04 (d, J = 8.3 Hz, 2H), 5.33 (s, 1H), 5.11 (d, J = 15.0 Hz, 1H), 4.38 (d, J = 15.0 Hz, 1H), 3.24
(dd, J = 47.1, 13.3 Hz, 2H), 2.17 (s, 1H). 13C NMR (100 MHz, CDCl3) δ 167.75, 143.11, 138.20,
137.38, 132.84, 132.78, 131.93, 129.40, 129.25, 128.86, 128.46, 128.25,
127.67, 123.58, 123.18, 72.40, 44.84, 43.40. HRMS (ESI) calcd for
C22H20ClN2O [M + H]+ 363.1259,
found 363.1260.

2-Benzyl-3-((4-bromobenzyl)amino)isoindolin-1-one
(12f)
Colorless oil (70.6 mg, 87%). 1H NMR (400 MHz,
CDCl3) δ 7.88 (d, J = 7.1 Hz, 1H),
7.63–7.45 (m, 3H), 7.42–7.21 (m, 7H), 6.99 (d, J = 8.2 Hz, 2H), 5.33 (s, 1H), 5.12 (d, J = 15.0 Hz, 1H), 4.38 (d, J = 15.0 Hz, 1H), 3.23
(dd, J = 48.1, 13.3 Hz, 2H), 2.12 (s, 1H). 13C NMR (100 MHz, CDCl3) δ 167.75, 143.06, 138.67,
137.34, 132.77, 131.94, 131.43, 129.75, 129.26, 128.87, 128.25, 127.68,
123.60, 123.16, 120.94, 72.37, 44.88, 43.42. HRMS (ESI) calcd for
C22H20BrN2O [M + H]+ 407.0754,
found 407.0755.

2-Benzyl-3-((2-chlorobenzyl)amino)isoindolin-1-one
(12g)
Colorless oil (60.8 mg, 84%). 1H NMR (400 MHz,
CDCl3) δ 7.89 (d, J = 6.8 Hz, 1H),
7.51 (dt, J = 13.7, 6.0 Hz, 3H), 7.35–7.22
(m, 6H), 7.16 (p, J = 6.9 Hz, 2H), 7.10–7.02
(m, 1H), 5.30 (s, 1H), 5.18 (d, J = 15.0 Hz, 1H),
4.25 (d, J = 15.0 Hz, 1H), 3.44 (dd, J = 67.5, 13.4 Hz, 2H), 2.35 (s, 1H). 13C NMR (100 MHz,
CDCl3) δ 167.62, 143.11, 137.35, 137.31, 133.78,
132.85, 131.86, 130.39, 129.49, 129.23, 128.84, 128.63, 128.28, 127.61,
126.97, 123.54, 123.27, 72.12, 43.71, 43.06. HRMS (ESI) calcd for
C22H20ClN2O [M + H]+ 363.1259,
found 363.1259.

2-Benzyl-3-(pentylthio)isoindolin-1-one (12h)
Colorless oil (62.9 mg, 92%). 1H
NMR [400 MHz, dimethyl
sulfoxide (DMSO)-d6] δ 7.76 (d, J = 7.4 Hz, 1H), 7.62 (s, 2H), 7.57–7.50 (m, 1H),
7.40 (d, J = 7.3 Hz, 2H), 7.33 (t, J = 7.4 Hz, 2H), 7.26 (t, J = 7.2 Hz, 1H), 7.08 (d, J = 10.3 Hz, 4H), 5.43 (d, J = 4.8 Hz,
1H), 4.90 (d, J = 15.1 Hz, 1H), 4.50 (d, J = 15.1 Hz, 1H), 3.80–3.60 (m, 1H), 3.22 (dd, J = 12.8, 4.3 Hz, 1H), 2.99 (dd, J = 12.7,
8.7 Hz, 1H), 2.13 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ 167.23, 144.30, 138.68, 138.43, 136.49,
133.02, 132.23, 130.18, 129.48, 129.22, 128.93, 128.43, 127.52, 127.17,
126.00, 123.99, 123.02, 73.03, 42.80, 42.71, 18.96. HRMS (ESI) calcd
for C23H23N2O [M + H]+ 343.1805, found 343.1805.

2-Benzyl-3-((furan-2-ylmethyl)amino)isoindolin-1-one
(12i)
Colorless oil (59.8 mg, 94%). 1H
NMR (400 MHz, CDCl3) δ 7.88 (d, J = 7.3 Hz, 1H), 7.60–7.44 (m, 3H), 7.38–7.22 (m, 5H),
7.22–7.11 (m, 1H), 6.88 (dd, J = 5.0, 3.5
Hz, 1H), 6.71 (d, J = 2.7 Hz, 1H), 5.31 (s, 1H),
5.19 (d, J = 15.0 Hz, 1H), 4.35 (d, J = 15.0 Hz, 1H), 3.61 (d, J = 13.9 Hz, 1H), 3.43
(d, J = 13.9 Hz, 1H), 2.26 (s, 1H). 13C NMR (100 MHz, CDCl3) δ 167.67, 143.39, 142.99,
137.30, 132.73, 131.95, 129.26, 128.86, 128.29, 127.67, 126.67, 124.83,
124.70, 123.59, 123.19, 71.95, 43.28, 40.65. HRMS (ESI) calcd for
C20H19N2O2 [M + H]+ 319.1441, found 319.1442.

2-Phenyl-3-thiomorpholinoisoindolin-1-one
(12j)
White solid (55.8 mg, 90%), mp = 101–103
°C. 1H NMR (400 MHz, CDCl3) δ 7.89
(d, J = 7.4 Hz, 1H), 7.66–7.58 (m, 1H), 7.58–7.48
(m, 4H),
7.44 (t, J = 7.8 Hz, 2H), 7.27 (dd, J = 9.7, 4.9 Hz, 1H), 5.85 (s, 1H), 3.02–2.82 (m, 2H), 2.74–2.56
(m, 2H), 2.58–2.35 (m, 4H). 13C NMR (100 MHz, CDCl3) δ 166.81, 142.05, 138.08, 132.59, 132.30, 129.52,
129.08, 126.24, 125.15, 123.86, 123.39, 81.76, 50.44, 28.46. HRMS
(ESI) calcd for C18H19N2OS [M + H]+ 311.1213, found 311.1213.

3-Thiomorpholino-2-(p-tolyl)isoindolin-1-one
(12k)
White solid (54.9 mg, 88%), mp = 95–97
°C. 1H NMR (400 MHz, CDCl3) δ 7.88
(d, J = 7.4 Hz, 1H), 7.55 (tt, J = 14.2, 7.2 Hz, 3H), 7.36 (d, J = 8.2 Hz, 2H),
7.24 (t, J = 9.1 Hz, 2H), 5.80 (s, 1H), 2.97–2.81
(m, 2H), 2.70–2.58 (m, 2H), 2.55–2.40 (m, 4H), 2.38
(s, 3H). 13C NMR (100 MHz, CDCl3) δ 166.85,
142.15, 136.14, 135.45, 132.70, 132.18, 129.74, 129.44, 125.23, 123.75,
123.36, 81.92, 50.47, 28.48, 21.12. HRMS (ESI) calcd for C19H21N2OS [M + H]+ 325.1369, found
325.1369.

2-Isopropyl-3-thiomorpholinoisoindolin-1-one
(12l)
White solid (46.9 mg, 85%), mp = 94–95
°C. 1H NMR (400 MHz, CDCl3) δ 7.79
(d, J = 7.0 Hz, 1H), 7.48 (dt, J = 19.2, 6.4
Hz, 3H), 5.13 (s, 1H), 4.31 (dt, J = 13.7, 6.8 Hz,
1H), 3.25–2.35 (m, 8H), 1.43 (dd, J = 15.3,
6.9 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ
167.32, 141.60, 133.28, 131.06, 128.96, 123.40, 123.07, 79.46, 44.43,
28.36, 21.42, 19.82. HRMS (ESI) calcd for C15H21N2OS [M + H]+ 277.1369, found 277.1369.

2-Phenethyl-3-thiomorpholinoisoindolin-1-one
(12m)
White solid (62.2 mg, 92%), mp = 90–91
°C. 1H NMR (400 MHz, CDCl3) δ 7.87
(d, J = 7.5 Hz, 1H), 7.57 (d, J =
5.1 Hz, 2H),
7.48 (dd, J = 9.0, 3.8 Hz, 1H), 7.37–7.23
(m, 5H), 5.37 (d, J = 14.7 Hz, 1H), 5.27 (s, 1H),
4.38 (d, J = 14.7 Hz, 1H), 1.92 (dt, J = 12.3, 7.3 Hz, 1H), 1.83–1.68 (m, 1H), 1.26 (d, J = 5.9 Hz, 2H), 1.20–1.10 (m, 4H), 0.79 (t, J = 6.7 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.51, 142.09, 139.29, 132.85, 131.33, 129.06, 128.82,
128.59, 126.50, 123.51, 123.21, 79.78, 50.03, 41.14, 34.95, 28.60.
HRMS (ESI) calcd for C20H23N2OS [M
+ H]+ 339.1526, found 339.1527.

2-(4-Methoxyphenethyl)-3-thiomorpholinoisoindolin-1-one
(12n)
White solid (64.0 mg, 87%), mp = 132–134
°C. 1H NMR (400 MHz, CDCl3) δ 7.82
(d, J = 7.0 Hz, 1H), 7.46 (ddt, J = 28.7, 14.8, 6.8 Hz, 3H), 7.16 (d, J = 8.5 Hz,
2H), 6.83 (d, J = 8.5 Hz, 2H), 4.79 (s, 1H), 4.07
(ddd, J = 13.7, 7.8, 6.0 Hz, 1H), 3.77 (s, 3H), 3.58–3.40
(m, 1H), 3.01–2.87 (m, 2H), 2.87–2.49 (m, 8H). 13C NMR (100 MHz, CDCl3) δ 167.48, 158.27,
142.11, 132.87, 131.31, 131.21, 129.72, 129.03, 123.46, 123.22, 114.00,
79.77, 55.27, 41.31, 33.96, 28.60. HRMS (ESI) calcd for C21H25N2O2S [M + H]+ 369.1631,
found 369.1631.

2-(4-Chlorophenethyl)-3-thiomorpholinoisoindolin-1-one
(12o)
White solid (67.0 mg, 90%), mp = 113–115
°C. 1H NMR (400 MHz, CDCl3) δ 7.82
(d, J = 7.1 Hz, 1H), 7.47 (ddd, J = 26.7, 13.1, 7.0 Hz, 3H), 7.29–7.23 (m, 2H), 7.19 (d, J = 8.3 Hz, 2H), 4.82 (s, 1H), 4.07 (ddd, J = 13.9, 7.9, 6.1 Hz, 1H), 3.64–3.38 (m, 1H), 2.96 (qd, J = 13.8, 6.9 Hz, 2H), 2.89–2.44 (m, 8H). 13C NMR (100 MHz, CDCl3) δ 167.55, 141.94, 137.65,
132.71, 132.29, 131.44, 130.14, 129.14, 128.69, 123.56, 123.26, 79.79,
50.05, 40.98, 34.19, 28.58. HRMS (ESI) calcd for C20H22ClN2OS [M + H]+ 373.1136, found 373.1138.

2-(4-Fluorobenzyl)-3-thiomorpholinoisoindolin-1-one (12p)
White solid (62.9 mg, 92%), mp = 121–123 °C. 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 6.9 Hz, 1H), 7.49 (ddd, J = 22.8, 11.5,
6.9 Hz, 3H), 7.30 (dt, J = 8.6, 4.4 Hz, 2H), 7.00
(t, J = 8.6 Hz, 2H), 5.14 (d, J =
14.6 Hz, 1H), 4.90 (s, 1H), 4.30 (d, J = 14.6 Hz,
1H), 2.69 (dd, J = 78.8, 24.8 Hz, 8H). 13C NMR (100 MHz, CDCl3) δ 167.41, 162.18 (d, J = 254 Hz), 160.96, 141.98, 133.29 (d, J = 3.1 Hz), 132.59, 131.60, 130.13 (d, J = 8.1 Hz),
129.20, 123.82, 123.39, 115.63, 115.42, 78.72, 50.05, 42.86, 28.52.
HRMS (ESI) calcd for C19H20FN2OS
[M + H]+ 343.1275, found 343.1275.

2-(4-Methylbenzyl)-3-thiomorpholinoisoindolin-1-one
(12q)
White solid (59.5 mg, 88%), mp = 125–127
°C. 1H NMR (400 MHz, CDCl3) δ 7.86
(d, J = 6.7 Hz, 1H), 7.48 (tt, J = 13.8, 6.8
Hz, 2H), 7.41 (d, J = 7.1 Hz, 1H), 7.21 (d, J = 7.9 Hz, 2H), 7.11 (d, J = 7.8 Hz, 2H),
5.19 (d, J = 14.5 Hz, 1H), 4.89 (s, 1H), 4.23 (d, J = 14.5 Hz, 1H), 2.69 (dt, J = 62.0, 4.5
Hz, 8H), 2.31 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 167.36, 142.12, 137.13, 134.38, 132.78, 131.46, 129.34,
129.09, 128.42, 123.73, 123.35, 78.56, 50.05, 43.28, 28.56, 21.13.
HRMS (ESI) calcd for C20H24NOS [M + H]+ 326.1573, found 326.1574.

Supporting Information Available
The Supporting Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.9b02853.1H
and 13C NMR spectra (PDF)



Supplementary Material
ao9b02853_si_001.pdf

 The authors declare no
competing financial interest.

Acknowledgments
We are grateful for financial
support from the Shandong Provincial
Natural Science Foundation (No. ZR2017BB033), the Youth Science Funds
of Shandong Academy of Sciences (No. 2018QN0030), and the National
Natural Science Foundation of China (No. 51503118).

Dedication
† Dedicated
to Prof. Jianwu Wang on the occasion of his 65th birthday.
==== Refs
References
a Speck K. ; Magauer T. 
The Chemistry
of Isoindole Natural
Products . Beilstein J. Org. Chem. 
2013 , 9 , 2048 –2078 . 10.3762/bjoc.9.243 .24204418  b Heugebaert T. S. A. ; Roman B. I. ; Stevens C. V. 
Synthesis of Isoindoles and Related
Iso-condensed Heteroaromatic Pyrroles . Chem.
Soc. Rev. 
2012 , 41 , 5626 –5640 . 10.1039/c2cs35093a .22782188  c Subbarayappa A. ; Patoliya P. U. 
An Efficient
Method for the Synthesis of 2,3-dihydro-1H-Isoindoles . Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 
2009 , 48 , 545 –552 . d Kundu N. G. ; Khan M. W. ; Mukhopadhyay R. 
Isoindolinones
(phthalimidines) . J. Indian Chem. Soc 
2001 , 78 , 671 –688 . e Ling-hua M. ; Zhi-yong L. ; Pommier Y. 
Non-Camptothecin DNA
Topoisomerase I Inhibitors in Cancer Therapy . Curr. Top. Med. Chem. 
2003 , 3 , 305 –320 . 10.2174/1568026033452546 .12570765  f Garcia-Carbonero R. ; Supko J. G. 
Current Perspectives
on the Clinical Experience, Pharmacology, and Continued Development
of the Camptothecins . Clin. Cancer Res. 
2002 , 8 , 641 –661 .11895891  g Pendrak I. ; Barney S. ; Wittrock R. ; Lambert D. M. ; Kingsbury W. D. 
Synthesis and Anti-HSV Activity of A-Ring-Deleted Mappicine
Ketone Analog. . J. Org. Chem. 
1994 , 59 , 2623 –2625 . 10.1021/jo00088a057 .
Bentley K. W.   In In the Isoquinoline
Alkaloids ; Ravindranath B.  , Ed.; Harwood Academic : Amsterdam , 1998 ; 361 –375 .
Tejesvi M. V. ; Pirttila A. M.   In Endophytes of Forest
Trees: Biology and Applications. Forestry Sciences ;Pirttila A. M. , Frank A. C.  , Eds.; Springer : Berlin , 2011 ; Vol. 80 , p 302 .
Takahashi I. ; Kawakami T. ; Hirano E. ; Yokota H. ; Kitajima H. 
Novel Phthalimidine
Synthesis. Mannich Condensation of o-phthalaldehyde
with Primary Amines Using 1,2,3-1H-benzotriazole and 2-mercaptoethanol
as Dual Synthetic Auxiliaries . Synlett 
1996 , 1996 , 353 –355 . 10.1055/s-1996-5438 .
Belliotti T. R. ; Brink W. A. ; Kesten S. R. ; Rubin J. R. ; Wustrow D. J. ; Zoski K. T. ; Whetzel S. Z. ; Corbin A. E. ; Pugsley T. A. ; Heffner T. G. ; Wise L. D. 
Isoindolinone Enantiomers
Having
Affinity for the Dopamine D4 receptor . Bioorg.
Med. Chem. Lett. 
1998 , 8 , 1499 –1502 . 10.1016/S0960-894X(98)00252-2 .9873377 
Mertens A. ; Zilch H. ; Konig B. ; Schafer W. ; Poll T. ; Kampe W. ; Seidel H. ; Leser U. ; Leinert H. 
Selective
Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. New 2,3-dihydrothiazolo[2,3-a]
Isoindol-5(9bH)-ones and Related Compounds With Anti-HIV-1 Activity . J. Med. Chem. 
1993 , 36 , 2526 –2535 . 10.1021/jm00069a011 .7689109 
a Zhuang Z. ; Kung M. ; Mu M. ; Kung H. F. 
Isoindol-1-one
Analogs of 4-(2′-methoxyphenyl)-1-[2′-[N-(2″-pyridyl)-p-iodobenzamido]ethyl]
Piperazine(p-MPPI) as 5-HT1A Receptor Ligands . J. Med. Chem. 
1998 , 41 , 157 –166 . 10.1021/jm970296s .9457239  b Norman M. H. ; Minick D. J. ; Rigdon G. C. 
Effect of Linking
Bridge Modifications on the Antipsychotic Profile of Some Phthalimide
and Isoindolinone Derivatives . J. Med. Chem. 
1996 , 39 , 149 –157 . 10.1021/jm9502201 .8568802 
Ferland J. M. ; Demerson C. A. ; Humber L. G. 
Synthesis of Derivatives of Isoindole
and of Pyrazino[2,1-a] Isoindole . Can. J. Chem. 
1985 , 63 , 361 –365 . 10.1139/v85-061 .
Lippmann W.  1,3-Dihydro-3-(2-hydroxy-2-methylpropyl)-2H-isoindol-1-one and its use . U.S. Patent 4,267,189 1981 ; Chem. Abstr. 1981, 95, 61988m.
a Wada T. ; Fukuda N. 
Effect of a New Anxiolytic,
DN-2327, on Learning and Memory in Rats . Pharmacol.,
Biochem. Behav. 
1992 , 41 , 573 –579 . 10.1016/0091-3057(92)90375-P .1350101  b Wada T. ; Fukuda N. 
Pharmacologic Profile of a New Anxiolytic,
DN-2327: Effect of Ro15-1788 and Interaction with Diazepam in Rodents . Psychopharmacology 
1991 , 103 , 314 –322 . 10.1007/BF02244284 .1676179 
a Liang M. ; Zhang S. ; Jia J. ; Tung C. H. ; Wang J. W. ; Xu Z. H. 
Synthesis of Spiroketals
by Synergistic Gold and Scandium Catalysis . Org. Lett. 
2017 , 19 , 2526 –2529 . 10.1021/acs.orglett.7b00804 .28474897  b Huang S. ; Li H. Y. ; Xie T. ; Wei F. ; Tung C.-H. ; Xu Z. H. 
Scandium-catalyzed Electrophilic
Alkene Difunctionalization: Regioselective Synthesis of Thiosulfone
Derivatives . Org. Chem. Front. 
2019 , 6 , 1663 –1666 . 10.1039/C9QO00138G . c Qi J. ; Teng Q. ; Thirupathi N. ; Tung C.-H. ; Xu Z. 
Diastereoselective
Synthesis of Polysubstituted Spirocyclopenta[c]furans by Gold-Catalyzed
Cascade Reaction . Org. Lett. 
2019 , 21 , 692 –695 . 10.1021/acs.orglett.8b03880 .30633533  d Kong L. ; Thirupathi N. ; Jia J. ; Xu Z. H. 
Synthesis
of 4H-Chromenes by Silver (I)-Catalyzed Cycloaddition of ortho-Quinone Methides with N-allenamides . Sci.
China: Chem. 
2019 , 62 , 80 –86 . 10.1007/s11426-018-9359-4 . e Thirupathi N. ; Wei F. ; Tung C.-H. ; Xu Z. 
Divergent
Synthesis of Chiral Cyclic Azides via Asymmetric Cycloaddition Reactions
of Vinyl Azides . Nat. Commun. 
2019 , 10 , 315810.1038/s41467-019-11134-8 .31320649 
For reviews, see:

a Martínez-Estibalez U. ; Gómez-SanJuan A. ; García-Calvo O. ; Aranzamendi E. ; Lete E. ; Sotomayor N. 
Strategies Based on Aryllithium and
N-Acyliminium Ion Cyclizations for the Stereocontrolled Synthesis
of Alkaloids and Related Systems . Eur. J. Org.
Chem. 
2011 , 2011 , 3610 –3633 . 10.1002/ejoc.201100123 . b Speckamp W. N. ; Moolenaar M. J. 
New Developments in the Chemistry
of N-acyliminium Ions and Related Intermediates . Tetrahedron 
2000 , 56 , 3817 –3856 . 10.1016/S0040-4020(00)00159-9 . c Speckamp W. N. ; Hiemstra H. 
Intramolecular Reactions of N-acyliminium
Intermediates . Tetrahedron 
1985 , 41 , 4367 –4416 . 10.1016/S0040-4020(01)82334-6 .
a Devineau A. ; Pousse G. ; Taillier C. ; Blanchet J. ; Rouden J. ; Dalla V. 
One-Pot Hydroxy Group
Activation/Carbon-Carbon Bond Forming Sequence Using a Bronsted Base/Broensted
Acid System . Adv. Synth. Catal. 
2010 , 352 , 2881 –2886 . 10.1002/adsc.201000602 . b Okitsu O. ; Suzuki R. ; Kobayashi S. 
Efficient
Synthesis of Piperidine Derivatives. Development of Metal Triflate-Catalyzed
Diastereoselective Nucleophilic Substitution Reactions of 2-Methoxy-
and 2-Acyloxypiperidines . J. Org. Chem. 
2001 , 66 , 809 –823 . 10.1021/jo001297m .11430100  c Raheem I. T. ; Thiara P. S. ; Peterson E. A. ; Jacobsen E. N. 
Enantioselective
Pictet-Spengler-Type Cyclizations of Hydroxylactams: H-Bond Donor
Catalysis by Anion Binding . J. Am. Chem. Soc. 
2007 , 129 , 13404 –13405 . 10.1021/ja076179w .17941641  d Muratore M. E. ; Holloway C. A. ; Pilling A. W. ; Storer R. I. ; Trevitt G. ; Dixon D. J. 
Enantioselective Bronsted Acid-Catalyzed
N-Acyliminium Cyclization Cascades. . J. Am.
Chem. Soc. 
2009 , 131 , 10796 –10797 . 10.1021/ja9024885 .19606900 
Peterson E. A. ; Jacobsen E. N. 
Enantioselective,
Thiourea-Catalyzed Intermolecular
Addition of Indoles to Cyclic N-acyl Iminium Ions . Angew. Chem., Int. Ed. 
2009 , 48 , 6328 –6331 . 10.1002/anie.200902420 .
For the asymmetric version of these reactions,
see:

a Brak K. ; Jacobsen E. N. 
Asymmetric Ion-Pairing Catalysis . Angew. Chem., Int. Ed. 
2013 , 52 , 534 –561 . 10.1002/anie.201205449 . b Akiyama T. 
Stronger Bronsted Acids . Chem.
Rev. 
2007 , 107 , 5744 –5758 . 10.1021/cr068374j .17983247 
For superacidic reagents-catalyzed
reactions,
see:

a Klumpp D. A. ; Zhang Y. ; O’Connor M. ; Esteves J. P. M. ; Almeida L. S. 
Aza-Nazarov Reaction and the Role
of Superelectrophiles . Org. Lett. 
2007 , 9 , 3085 –3088 . 10.1021/ol0711570 .17630754 
For Lewis acid-catalyzed reactions, see:

a Boiaryna L. ; Mkaddem M. K. E. ; Taillier C. ; Dalla V. ; Othman M. 
Dual Hard/Soft Gold Catalysis: Intermolecular Friedel-Crafts-Type
α-Amidoalkylation/Alkyne Hydroarylation Sequences by N-Acyliminium
Ion Chemistry . Chem. – Eur. J 
2012 , 18 , 14192 –14200 . 10.1002/chem.201202225 .22996700  b Peixoto S. ; Nguyen T. M. ; Crich D. ; Delpech B. ; Marazano C. 
One-Pot Formation of Piperidine- and Pyrrolidine-Substituted
Pyridinium Salts via Addition of 5-Alkylaminopenta-2,4-dienals to
N-Acyliminium Ions: Application to the Synthesis of (±)-Nicotine
and Analogs . Org. Lett. 
2010 , 12 , 4760 –4763 . 10.1021/ol101783c .20882970 
For Brønsted acid-catalyzed reactions,
see:

a Muratore M. E. ; Shi L. ; Pilling A. W. ; Storer R. I. ; Dixon D. J. 
Exploiting a Novel Size Exclusion Phenomenon for Enantioselective
Acid/Base Cascade Catalysis . Chem. Commun. 
2012 , 48 , 6351 –6353 . 10.1039/c2cc32258g . b Gómez-SanJuan A. ; Sotomayor N. ; Lete E. 
Enantioselective Intramolecular
α-Amidoalkylation Reaction in the Synthesis of Pyrrolo[2,1-a]
Isoquinolines . Tetrahedron Lett. 
2012 , 53 , 2157 –2159 . 10.1016/j.tetlet.2012.02.057 . c Xie Y. ; Zhao Y. ; Qian B. ; Yang L. ; Xia C. ; Huang H. 
Enantioselective N-H Functionalization of Indoles with
α, β-Unsaturated γ-Lactams Catalyzed by Chiral Bronsted
Acids . Angew. Chem., Int. Ed. 
2011 , 50 , 5682 –5686 . 10.1002/anie.201102046 .
a Boiaryna L. ; Mkaddem M. K. E. ; Taillier C. ; Dalla V. ; Othman M. 
Dual Hard/Soft Gold Catalysis: Intermolecular
Friedel-Crafts-Type α-Amidoalkylation/Alkyne Hydroarylation
Sequences by N-Acyliminium Ion Chemistry . Chem.
– Eur. J 
2012 , 18 , 14192 –14200 . 10.1002/chem.201202225 .22996700  b Yang T. ; Campbell L. ; Dixon D. J. 
A Au(I)-Catalyzed
N-Acyl Iminium Ion Cyclization Cascade . J. Am.
Chem. Soc. 
2007 , 129 , 12070 –12071 . 10.1021/ja074550+ .17877351 
Ben
Othman R. ; Affani R. ; Tranchant M.-J. ; Antoniotti S. ; Dalla V. ; Duñach E. 
N-Acyliminium
Ion Chemistry: Highly Efficient and Versatile Carbon-Carbon Bond Formation
by Nucleophilic Substitution of Hydroxy Groups Catalyzed by Sn(NTf2)4 . Angew. Chem., Int. Ed. 
2010 , 49 , 776 –780 . 10.1002/anie.200906036 .
Dutta M. ; Mandal S. M. ; Pegu R. ; Pratihar S. 
PdII/AgI Catalyzed Room-Temperature Reaction of γ-Hydroxy
Lactams:
Mechanism, Scope, and Antistaphylococcal Activity . J. Org. Chem. 
2017 , 82 , 2193 –2198 . 10.1021/acs.joc.6b02378 .28094945 
a Matsumura Y. ; Minato D. ; Onomura O. 
Highly Enantioselective
Introduction of Bis(alkoxycarbonyl) Methyl Group into the 2-position
of Piperidine Skeleton . J. Organomet. Chem. 
2007 , 692 , 654 –663 . 10.1016/j.jorganchem.2006.04.039 . b Onomura O. ; Kanda Y. ; Nakamura Y. ; Maki T. ; Matsumura Y. 
Copper Ion-Catalyzed Asymmetric Carbon-Carbon Bond-Forming
Reaction at the 2-position of a Piperidine Skeleton . Tetrahedron Lett. 
2002 , 43 , 3229 –3231 . 10.1016/S0040-4039(02)00449-5 .
a Sasamoto N. ; Dubs C. ; Hamashima Y. ; Sodeoka M. 
Pd(II)-Catalyzed Asymmetric Addition of Malonates to
Dihydroisoquinolines . J. Am. Chem. Soc. 
2006 , 128 , 14010 –14011 . 10.1021/ja065646r .17061867  b Dubs C. ; Hamashima Y. ; Sasamoto N. ; Seidel T. M. ; Suzuki S. ; Hashizume D. ; Sodeoka M. 
Mechanistic Studies
on the Catalytic Asymmetric Mannich-Type Reaction with Dihydroisoquinolines
and Development of Oxidative Mannich-Type Reactions Starting from
Tetrahydroisoquinolines . J. Org. Chem. 
2008 , 73 , 5859 –5871 . 10.1021/jo800800y .18578499 
Zhang Y. ; DeSchepper D. J. ; Gilbert T. M. ; Sai K. K. S. ; Klumpp D. A. 
Superacid
Promoted Reactions of N-acyliminium Salts and Evidence for the Involvement
of Superelectrophiles . Chem. Commun. 
2007 , 4032 –4034 . 10.1039/b708760h .
Palillero-Cisneros A. ; Bedolla-Medrano M. ; Ordonez M. 
Efficient PhB(OH)2-Catalyzed
One-Pot Synthesis of 3-Substituted Isoindolin-1-ones and Isobenzofuran-1(3H)-ones
under Solvent Free Conditions . Tetrahedron 
2018 , 74 , 4174 –4181 . 10.1016/j.tet.2018.05.086 .
Cao Z. P. ; Zhu H. B. ; Meng X. ; Guan J. ; Zhang Q. ; Tian L. J. ; Sun X. J. ; Chen G. ; You J. M. 
Metal-Free
Reaction of ortho-Carbonylated Alkynyl-Substituted
Arylaldehydes with Common Amines: Selective Access to Functionalized
Isoindolinone and Indenamine Derivatives . Chem.
– Eur. J. 
2016 , 22 , 16979 –16985 . 10.1002/chem.201603045 .27734539 
Maity A. K. ; Roy S. 
Multimetallic Iridium-Tin
(Ir-Sn3) Catalyst in N-Acyliminium Ion
Chemistry: Synthesis of 3-Substituted
Isoindolinones via Intra and Intermolecular Amidoalkylation Reaction . Adv. Synth. Catal. 
2014 , 356 , 2627 –2642 . 10.1002/adsc.201400234 .
Katritzky A. R. ; Mehta S. ; He H. Y. 
Syntheses of Pyrrolo and Indoloisoquinolinones
by Intramolecular Cyclizations of 1-(2-Arylethyl)-5-benzotriazolylpyrrolidin-2-ones
and 3-Benzotriazolyl-2-(2-arylethyl)-1-isoindolinones . J. Org. Chem. 
2001 , 66 , 148 –152 . 10.1021/jo001273f .11429892 
Rao H. S. P. ; Prabhakaran J. ; Kanniyappan S. ; Rao A. V. B. 
Copper (cat)
and Phenylboronic Acid Mediated Deformylative C-N coupling of Isoindolinone-3-ols
with Formamides Provide C(3) Aminoisoindolinones . J. Chem. Sci. 
2018 , 130 , 7410.1007/s12039-018-1474-8 .

